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ABSTRACT 
 
Shoulder pain is a common complaint of diabetic patients that causes motion limitations and 
functional disability. Adhesive capsulitis (AC) is the most common disabling shoulder 
disorder. There is no optimal non-surgical treatment for managing AC in patients with diabetes. 
Furthermore, the impact of diabetes on shoulder recovery and factors predicting shoulder 
function following shoulder arthroplasty is not well investigated.  
Purpose and Methods 
The main purpose of this thesis was to inform clinical practice about the best intervention for 
managing AC in diabetic patients,  and to assess the impact of diabetes on functional outcomes 
after shoulder arthroplasty, with the following objectives: 1) To systematically review clinical 
research evaluating nonsurgical interventions for managing AC in diabetic patients; 2) To pilot 
test study procedures and estimating the effects of incorporating a progressive walking program 
as an adjunct to a regular physiotherapy program for managing AC in diabetic patients; 3) To 
examine the effect of diabetes on shoulder function and physical health status; And 4) To 
determine factors that predict shoulder functional outcomes following shoulder arthroplasty.  
Results  
Eight randomized trials (RCTs) were evaluated in a systematic review. The largest effect size 
(2.0) was reported for joint mobilization plus exercises. The pilot RCT (n = 8) found that 
regular physiotherapy (PT) group and regular physiotherapy program plus progressive walking 
group (PT+) may improve functional performance and other outcomes, with a mean change of 
PT = 3817, and PT+ = 633 seconds for Functional Impairment Test-Hand and 
Neck/Shoulder/Arm (FIT-HaNSA) test from baseline to six weeks follow-up. A sample size of 
89 participants per group is needed for future studies. Diabetic and non-diabetic patients 
showed significant improvements in function and physical health status following shoulder 
arthroplasty with no significant differences between groups. At one year after arthroplasty, 
residual pain significantly predicted poorer shoulder function.  
Conclusions 
We found that low-quality evidence suggested large effects of joint mobilization plus exercises 
on AC in people with diabetes. The pilot trial established that conducting a large-scale study 
to assess the effect of the physiotherapy program for managing AC is feasible. Patients with 
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and without diabetes may get equal surgical benefits, and residual pain may cause limitations 
in shoulder function one year after arthroplasty.   
 
Keywords 
Adhesive capsulitis, Diabetes, Physical Therapy, Pilot trial, Shoulder arthroplasty, Systematic 
review. 
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LAY ABSTRACT 
 
Frozen Shoulder is a common problem that occurs five times more frequently in patients with 
diabetes. Frozen Shoulder causes pain and disability. The usual treatments reduce shoulder 
pain and disability, but these treatments often fail for people with diabetes. Currently, we are 
not sure what is the best treatment to manage Frozen Shoulder in patients with diabetes. We do 
not know how diabetes can affect recovery after shoulder replacement surgery. Also, we are 
not sure what factors can affect function after shoulder replacement surgery.   
This thesis includes five papers. The first paper aimed at reviewing the literature of diabetic 
shoulder. The second paper evaluated the effect of different conservative treatments that reduce 
pain and disability in patients who have Frozen Shoulder. The third paper tests whether adding 
a walking program to the usual care will result in better pain relief, motion and function. The 
fourth paper assesses if diabetes impacts recovery after shoulder replacement surgery. The fifth 
paper aimed to find factors that might affect shoulder joint function after replacement surgery. 
Results show that exercises and steroid injections may improve shoulder pain and function in 
patients with diabetes who have Frozen Shoulder. We think it is also possible to conduct a large 
study to assess if adding a walking program to shoulder exercises would better improve 
shoulder function in patients with Frozen Shoulders. We found that diabetes does not affect 
recovery after shoulder replacement surgery. We also found that the presence of pain at one 
year after surgery may cause shoulder disability.  
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CHAPTER 1 
 
THE DIABETIC SHOULDER- A LITERATURE REVIEW 
 
 
A form of this manuscript is published in the Journal of Diabetes and Clinical Research  
 
 
Citation:  
 
Alsubheen SA, MacDermid JC, Overend TJ, Faber KJ. (2019). The diabetic shoulder – A 
literature review. Journal of Diabetes and Clinical Research, 1(2),59-70. 
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Abstract 
 
Shoulder pain is one of the most common complaints of patients with diabetes that causes 
motion limitation, functional disability and decreased quality of life. There is a higher 
prevalence of shoulder disorders in patients with diabetes, with adhesive capsulitis (AC) and 
rotator cuff (RC) tendinopathy being the most common disabling shoulder disorders. The 
pathophysiology that predisposes patients with diabetes for the development of AC or RC 
tendinopathy is not well-understood. However, the increased glycosylation of collagen fibers 
of the joint capsule, tendons and ligaments, and the diabetic microangiopathy might potentially 
explain the pathological process. Although some therapeutic interventions have been shown to 
be effective in managing shoulder disorders, several studies have reported higher shoulder pain, 
reduced mobility, poor functional outcomes, and a diminished response to treatment in patients 
with diabetes than patients without diabetes. In the current literature, there is a lack of studies 
on the best treatment approach for managing shoulder disorders in patients with diabetes. 
Furthermore, the effect of diabetes on shoulder function after shoulder arthroplasty is not well 
investigated. Future research is required to examine the effectiveness of different surgical and 
non-surgical interventions on managing shoulder disorders in patients with diabetes. In 
addition, more research is required to investigate the impact of diabetes on shoulder recovery 
and factors predicting shoulder function following shoulder arthroplasty. 
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1.1 Introduction to the thesis 
 
1.1.1 Functional anatomy of the shoulder complex   
 
The shoulder complex is composed of three bony structures: the clavicle, scapula, and humerus, 
which are connected to form three synovial (glenohumeral, acromioclavicular, and 
sternoclavicular) and two functional (scapulothoracic and subacromial) joints [1]. These 
articulations link the upper extremity to the thorax and allow for great mobility of the arm. As 
a result, the hand can be placed and moved through a large volume of space [2].  
The combined mechanics of the articular joints and the surrounding soft tissue structures 
(muscles, capsules, and ligaments) interact to provide mobility and stability of the shoulder 
complex. In a normally functioning shoulder complex, both static and dynamic stabilizers 
result in a broad range of joint movements and provide adequate stability. However, the unique 
design of the shoulder complex that provides mobility with reduced stability also makes it 
highly susceptible to dysfunction and injury [1,2].  
1.1.1.1 Glenohumeral joint (shoulder joint) 
 
The glenohumeral joint is a triaxial joint that connects the head of the humerus with the glenoid 
fossa of the scapula. This joint has greater mobility than any other joint in the body [1]. Only 
25% to 30% of the humeral head contacts the glenoid fossa at any given time. This anatomical 
configuration results in an extensive joint mobility but low stability [2]. However, the interplay 
between the static (capsule, labrum, ligaments) and the dynamic (muscle) forces provide a 
precise constraint of the center of rotation through a large arc of motion [3].  
The glenoid labrum deepens the fossa to provide additional stability and serves as the 
attachment site for the joint capsule. The joint capsule along with the glenohumeral and 
coracohumeral ligaments tighten to limit joint translation and provide static stability to the 
shoulder. Further static stability is provided through the adhesive and cohesive forces of the 
synovial fluid and the negative joint pressure that hold joint surfaces together [1,2].  
During arm elevation, the dynamic stability of the glenohumeral joint is provided mainly by 
the muscular forces of the rotator cuff and the deltoid. The rotator cuff consists of the 
subscapularis, supraspinatus, infraspinatus and teres minor muscles. This group of muscles 
inserts onto the facets of the greater and lesser tuberosities and provides a continual ring shaped 
insertion from posterior-inferior to anterior-inferior on the proximal humerus [2]. The 
contraction of the supraspinatus, along with the deltoid, causes arm elevation. The contraction 
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of the infraspinatus and the teres minor muscles provides an external rotation force while the 
internal rotation force results from the contraction of the subscapularis muscle [1].  
The co-contraction of the rotator cuff produces a concavity-compression effect directed toward 
the glenoid center to promote glenohumeral joint stability, while asymmetric contraction 
causes humeral head rotation (steering mechanism) and depression during shoulder abduction 
motion. However, due to the small size of the rotator cuff and its proximity to the joint center 
of rotation, they generate lower muscle forces when compared to the larger and more 
superficial muscles (deltoid, latissimus dorsi, trapezius, and pectoralis major) [2].  
The long head of the biceps muscle plays a role in stabilizing the head of the humerus. Along 
with the rotator cuff, it functions to depress the humeral head during shoulder abduction. In 
addition, the contraction of the long head of biceps during the late phase of throwing reduces 
anterior translation and resists external rotation [4]. Further static stabilization is promoted by 
the tension placed on the static restraints and the glenohumeral ligaments that limit excessive 
translations of humeral head [1]. 
1.1.1.2 Acromioclavicular and sternoclavicular joints 
 
The acromioclavicular and the sternoclavicular joints are triaxial joints that connect the clavicle 
to the acromion process of the scapula and the sternum, respectively. The stability of the 
acromioclavicular joint is maintained through static stabilizers composed of a thick capsule, an 
intra-articular disc, and the coracoclavicular ligament. The acromioclavicular ligaments 
restraint the posterior translation of the acromioclavicular joint, while the coracoclavicular 
ligaments restraint the vertical displacement of the joint [5].  
The small sternoclavicular joint is the only joint that connects the shoulder complex to the axial 
skeleton. The stability of the sternoclavicular joint is provided by the surrounding ligaments 
composed of the intra-articular disc-ligament, costoclavicular ligament and interclavicular 
ligament which act as a checkrein against medial displacement, excessive upward rotation and 
excessive downward rotation of the clavicle, respectively [1,2].   
1.1.1.3 Scapulothoracic articulation and muscles  
 
The scapulothoracic articulation is a functional joint (not a true joint) that represents a space 
between the thoracic cage and the anterior scapula. There is considerable soft tissue flexibility 
that allows a relatively smooth slide of the scapula along the underlying thorax. The 
scapulothoracic articulation synchronizes with the glenohumeral joint and allows for 150° to 
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180° of shoulder range of motion (ROM) into flexion or abduction with elevation. For every 
2° of glenohumeral elevation, there is 1° of scapulothoracic elevation. However, this ratio can 
vary among individuals and for any part of the arc of movement [1,2].  
Several muscles that originate from or insert into the scapula provide motion and dynamically 
stabilize the scapula. In the dependent position, the scapula is maintained in downward rotation, 
forward tilting, and protraction position. This position is stabilized by the balanced forces of 
the trapezius, serratus anterior, levator scapula, and rhomboids musculature. The dependent 
position of the scapula is further maintained by the static stabilization of the cohesive forces of 
the subscapular bursa, acromioclavicular and sternoclavicular joint ligaments, and the 
scapulothoracic facia [1,2].  
During active arm motion, the scapulohumeral muscles maintain an effective length-tension 
relationship and function to stabilize and control the position of the scapula, allowing a smooth 
movement of the humerus. The serratus anterior maintains the medial angle of the scapula 
against the chest wall and along with the upper and medial trapezius, upwardly rotates the 
scapula during arm elevation [1,2].  
During flexion and pushing activities, the serratus anterior muscle protracts the scapula on the 
thorax. However, during arm extension or pulling activities, the rhomboids retract the scapula 
and cause downward rotation while the latissimus dorsi, teres major, and rotator cuff muscles 
function to exert rotational forces that cause the inferior scapula to move away from the midline 
(upward rotation). In addition, these muscles eccentrically contract to control the upward 
rotation and protraction of the scapula. The levator scapula elevates the superior angle, 
resulting in upward and medial rotation of the scapula, while the pectoralis minor protracts and 
rotates the scapula inferiorly [1,2].  
1.1.2 Common musculoskeletal disorders of the shoulder joint  
 
Musculoskeletal disorders affecting shoulder joint can either lead to hypomobility (restricted 
mobility) or hypermobility (excess mobility) of the joint. Common pathologies that limit 
shoulder movements include arthritis [rheumatoid arthritis (RA) or osteoarthritis (OA)], 
adhesive capsulitis (AC)/frozen shoulder, and rotator cuff tendinopathy (RC)/impingement 
syndrome [1]. 
Hypermobility of the shoulder joint causes joint instability and can be atraumatic or traumatic. 
Atraumatic joint hypermobility can be due to an inherent generalized connective tissue laxity 
 6 
or secondary to repeated microtrauma. However, traumatic instability is usually caused by high 
direct or indirect applied forces to the shoulder joint that often lead to joint dislocation 
(complete separation of the articular surfaces) and soft tissue damage. Further, inherent 
instability may be a pre-disposing factor to traumatic dislocation, especially with repetitive 
stressful overhead activities. A secondary effect of joint hypermobility is painful shoulder 
syndrome [1].  
 1.1.2.1 Shoulder arthritis 
 
Arthritis can be defined as joint pain or joint disease. It can affect people of all ages, genders, 
and races. Overtime, arthritis can lead to impaired mobility and functional limitations. Many 
types of arthritis may affect shoulder joint including: 
• Osteoarthritis: is a chronic degenerative disorder affecting the articular cartilage of 
shoulder joint leading to pain and stiffness. With degeneration, the capsule also 
becomes thickened causing further loss of rotational movements. Shoulder OA is not 
as common as OA of the knee or hip, however, it is reported to affect 32.8% of patients 
over the age of 60 years [6]. The etiology of the primary shoulder OA is unknown but is 
related to age (over the age of 65), genetics and sex; women are affected more 
frequently than men. Secondary OA may occur as a result of repeated micro or high 
impact trauma, chronic dislocation, or infection [6,7]. 
• Rheumatoid arthritis: is an autoimmune, chronic, progressive inflammatory, 
systematic disorder primarily affecting the synovial joint capsule and connective tissue. 
Shoulder RA results in pain, loss of ROM, stiffness, progressive deformity and 
functional disability [1,8]. The prevalence of shoulder RA is 1% worldwide and presents 
in about 5% of people over the age of 70 years. It affects women more frequently than 
men with a ratio of 3:1. Shoulder symptoms develop in about 91% of patients with 
long-standing RA (more than 5 years) [8].  
• Post-traumatic/ immobilization arthritis occurs in response to an injury or fracture 
to the shoulder; or from lack of movement, which causes rapid destruction of articular 
cartilage. Immobilization arthritis could also occur as a secondary effect of medical 
conditions such as stroke, diabetes, or heart disease [1].  
 1.1.2.2 Rotator cuff tendinopathy/impingement syndrome 
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Rotator cuff tendinopathy is a progressive disorder of the rotator cuff tendons. The condition 
begins with acute tendinitis of the muscle tendon (mainly the supraspinatus) and progresses to 
tendinosis with degeneration and partial thickness tears. The condition may result in a full 
thickness rupture. Rotator cuff tendinopathy causes pain in the shoulder region, leading to a 
restricted and painful arc of motion, sleep disturbance, and shoulder dysfunction [1,9]. 
The etiology of RC tendinopathy is often multifactorial, and the symptoms are usually brought 
on by repetitive or excessive overhead activities. Both intrinsic and extrinsic mechanisms play 
a role in the pathology development and progression. Extrinsic factors are defined as those 
causing narrowing of the subacromial space during arm elevation, leading to mechanical 
compression/impingement and irritation of the soft tissues (rotator cuff and subacromial bursa). 
Extrinsic factors could be anatomical, such as the shape and angle of the acromion, or 
biomechanical (postural and muscular impairments) or a combination of both. The extrinsic 
mechanism was first described by Codman (1934) and the concept was popularized by Neer in 
the 1980s who coined the term subacromial impingement syndrome [9,10].  
On the other hand, intrinsic factors affect the structural integrity of the musculotendinous 
structures, leading to RC tendon degeneration. These factors include vascular changes in the 
RC tendons, tissue tension overload, and collagen disorientation and degeneration. The 
condition is observed most often in patients over 40 years old and disease prevalence increases 
with age and can affect more than 50% of the population greater than 60 years old [1,9].  
1.1.2.3 Adhesive capsulitis/ frozen shoulder 
 
Adhesive capsulitis (AC), also known as ‘frozen shoulder’, is characterized by the development 
of dense adhesions and capsular thickening leading to a progressive and painful restriction of 
shoulder ROM and functional disability [11]. The condition does not cause arthritic changes in 
the joint cartilage and bone as seen with OA and RA. The onset is gradual and usually occurs 
between the ages of 40 and 65 years [1]. Further, it is five times more common in people with 
diabetes and is more frequent in women [12].  
Codman (1934) was the first to describe the condition, coin the term ‘frozen shoulder’ and 
define the common criteria shared by most frozen shoulder patients which include slow onset 
of pain, inability to sleep on the affected side, painful and restricted shoulder abduction and 
external rotation motions, and normal radiographs [13].  
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The frozen shoulder was termed shoulder adhesive capsulitis by Neviaser (1945) who found 
thickening and contracture of the joint capsule and described peeling the capsule from humeral 
head as peeling adhesive plaster from skin. In 1969, Lundberg suggested to subdivide frozen 
shoulder, based on Codman criteria, into two groups: primary or idiopathic frozen shoulder, 
which has no clear underlying cause, and secondary frozen shoulder, in which the condition is 
secondary to soft tissue injury, OA, RA, trauma, or secondary to a known systemic disease 
such as diabetes [13].  
For many years, AC has been described as a self-limiting condition that progresses through a 
natural history of painful, frozen and thawing phases, leading to full recovery without 
treatment. However, a recent systematic review assessed the quality of the evidence that 
describes the theory of AC phases and the theory of full recovery without treatment [14]. The 
authors reported a lack of evidence to support the theoretical phases of AC. In addition, this 
review found that moderate-quality evidence supported an early improvement in shoulder 
ROM and function that slows over time and leads to long-term limitations [14].  
The pathophysiology of idiopathic AC was studied in a recent systematic review that included 
13 observational studies. There was consistent agreement among studies that the pathological 
changes in the anterior shoulder joint capsule originated from the subscapularis bursa, at the 
base of the origin of the long head of the biceps (rotator interval) [15]. These pathological 
changes were described as a proliferation of fibroblasts arranged alongside layers of dense 
collagen tissue, leading to capsular contracture. This fibrous tissue was noted to become tight 
if the arm was placed in external rotation, forming a checkrein to further movement (the 
presence of pathological fibrous tissue prevents full joint motion). The systematic review 
suggested that fibrotic changes were associated with primary frozen shoulder [15].  
Mechano-transduction is another potential mechanism that might trigger the development of 
AC. Mechano-transduction refers to the mechanism by which cells convert external mechanical 
stimuli or force into a set of biochemical reactions that elicit adaptive responses including 
positional location and adhesion, contractile activation, responsiveness to shear stress and 
growth [16]. Mechanical loading induces hypertrophy and strengthening of skeletal muscles, 
tendons, ligaments and bones and have been long been implicated in regulating many 
physiologic and pathologic processes. Even when forces are not externally applied, cells 
experience endogenous mechanical forces that are generated by their internal cytoskeletal 
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machinery. Such cell-generated forces appear to alter many basic cellular functions, such as 
cell proliferation, differentiation, sorting and migration [16].  
Tissue samples from patients with AC demonstrated a dense collagen matrix and excessive 
proliferation of fibroblasts and contractile myofibroblasts at the anterior part of the joint 
capsule [15]. The increase in collagen cross-linking and density lead to the development of 
fibrous tissue which alters the mechanical properties of the extracellular matrix of articular 
capsule, ligaments and muscle-tendon units by making tissue stiffer and weaker [16,17].  
Research investigating the mechano-transduction mechanism demonstrated that the presence 
of external and internal loading might alter numerous cellular functions including migration, 
prefiltration and differentiation, making tissue stiffer and weaker [16]. However, these studies 
were inconclusive about AC pathophysiology and no study directly linked AC to the mechano-
transduction mechanism.  
 
1.1.3 Association between diabetes and shoulder disorders  
 
Diabetes is a metabolic condition that is characterized by persistent hyperglycemia due to 
insulin deficiency, impaired effectiveness of insulin action, or both. Diabetes is considered one 
of the most challenging health problems in the 21st century. It is one of the most disabling 
diseases and the fifth leading cause of death in most developed countries [18,19].  
Based on the etiology, diabetes can be classified into two main types: type 1 diabetes, which 
results from cell-mediated autoimmune destruction of pancreatic islet beta cells causing the 
loss of insulin production; and type 2 diabetes, which occurs due to insulin deficiency and/or 
insulin resistance. However, other types of diabetes do exist such as gestational diabetes 
(occurs during pregnancy), type 3 diabetes (resistance to insulin in the brain), secondary 
diabetes (as a consequence of other medical condition), neonatal diabetes (affects babies under 
6 months old), and many others [18].   
Type 1 diabetes occurs more commonly in children, while type 2 diabetes is seen more 
frequently among adults and constitutes about 85% to 95% of all diabetes in developed 
countries. Diabetes can be found in almost every population in the world. The global burden 
of diabetes is estimated to be 10.4% for persons aged 20-79 years by the year 2040. In Canada, 
it is predicted that there will be a large increase in the number of people with diabetes from 9% 
in 2003 to 11.2% in 2025. In addition, the prevalence of diabetes is more than four times higher 
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among First Nations women than non-First Nations women and more than 2.5 times higher 
among First Nations men as compared to non-First Nations men  [18–20] 
Diabetes has many well-described complications including neuropathy, cardiovascular 
diseases, retinopathy, stroke, peripheral vascular disease (amputation), and renal failure that 
result in disability, reduced life span, and increased health cost [18]. Complications involving 
the musculoskeletal system are generally less well-described. Shoulder pain is one of the most 
common complaints of patients with diabetes that causes motion limitation, functional 
disability and decreased quality of life. There is higher prevalence of shoulder disorders in 
patients with diabetes, with AC and RC tendinopathy being the most common disabling 
shoulder disorders [11,12].  
The association between diabetes and AC was first recognized by Bridgman (1972) who found 
that 10.8% of patients with diabetes had AC as compared to 2.3% patients without diabetes [21]. 
Subsequent studies have supported this association and reported a prevalence of AC in 10-76% 
type 1 and 7-30% type 2 diabetes as compared to 0-10% in the general population [22–25]. 
Adhesive capsulitis was also reported to be associated with age in both types of diabetes [22] 
and with the duration in type 1 diabetes [23,24,26].  
Patients with diabetes, with or without the use of insulin, have a high risk for developing RC 
tendinopathy, with a hazard ratio (HR) of 2.11 as compared with those without diabetes [11].  In 
addition, chronic RC tendinopathy and shoulder pain have been associated with diabetes [27]. 
Further, patients with diabetes have been reported to have a concurrent diagnosis of AC and 
RC tendinopathy, leading to shoulder pain and contracture [28]. Furthermore, diabetes has been 
associated with postoperative stiffness after rotator cuff repair [28,29].  
The pathophysiology that predisposes patients with diabetes for the development of AC or RC 
disease is not well-understood. However, the two diseases might share similar diabetes-related 
mechanisms [11]. Indeed, several potential mechanisms have been suggested that explain the 
pathological process including the increased glycosylation of collagen fibers of the joint 
capsule and the diabetic microangiopathy [11,17,30].  
Collagen is the main structural protein in the extracellular matrix in the various connective 
tissue in the body. Normally, collagen fibers are glycosylated meaning that collagen protein 
molecules have sugar molecules covalently bonded to them through a specific enzymatic 
process. However, in diabetic tissue, hyperglycemia can cause a non-enzymatic covalent 
bonding of sugar molecules to the collagen fibers. Over time, the glycating sugar reacts further 
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leading to the abnormal biochemical formation of pathological collagen tissue known as 
advanced glycation end-products (AGEs). These AGEs increase crosslinking in the collagen 
fibers of shoulder capsule, tendons and ligaments, making making these structures stiffer and 
weaker [11,17,30,31]. The cross-linking collagen accumulate in the shoulder capsule leading to 
joint stiffness and chronic inflammatory process in the synovium [11]. In addition, an increase 
in cell proliferation and cellularity of fibroblasts may result in dense layers of collagen tissue, 
leading to capsular contracture [11,30,31]. 
Further, arthroscopic biopsies of joint synovium in patients with diabetes showed greater 
amounts of endothelial growth factors and reduced amounts of inflammatory growth factors. 
These findings explained the prolonged course and severity of AC in patients with diabetes [31]. 
However, other studies reported that AGEs interact with the receptors on the surface of 
tenocytes and fibroblasts, leading to chronic inflammatory changes in the joint synovium, 
which contribute to capsular fibrosis of the shoulder joint [11,30]. 
The impaired microcirculation (diabetic microangiopathy) is another pathological process that 
may contribute to the development of AC and RC tendinopathy in patients with diabetes. There 
is a consensus among studies that uncontrolled hyperglycemia leads to macrovascular and 
microvascular complications in patients with diabetes [11,30].  
It is documented that AGEs are prevalent in the diabetic vasculature and contribute to the 
development of atherosclerosis. AGE cross-linking of collagen fibers in the basement 
membrane of the extracellular matrix leads to thickening of the basement membrane, stiffness 
of blood vessels and alterations in vascular contractility. As a result, tissue hypoxia occurs 
causing joint tissue destruction and degenerative changes [11,30]. Moreover, AGEs induce 
vascular endothelial growth factor which causes synovial cell proliferation in the subacromial 
bursa synovium, leading to the development of shoulder joint contracture in patients with 
diabetes who have AC and RC tendinopathy [29].  
1.1.4 Assessment of shoulder joint 
 
The assessment of the shoulder joint is essential for the diagnosis and formulation of an 
appropriate management for patients with shoulder disorders. The assessment usually starts 
with obtaining a detailed history about patient's demographics, medical history, and the onset 
of the condition symptoms, followed by inspection and palpation. The assessor inspects 
shoulders for symmetry and deformity and palpates joints for any tenderness, swelling, or 
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anatomic abnormalities. It is also essential to examine the neck area to rule out cervical spine 
pathology and referred neck pain [32,33].  
One of the next steps in diagnosing shoulder pathology is to measure shoulder active and 
passive ROM including forward flexion, abduction, external and internal rotation. The 
assessment of shoulder ROM can be performed by visual estimation or by using goniometer. 
Goniometric measurements are extensively used in physical therapy for measuring any joint 
motion in degrees. Measuring shoulder joint active and passive ROM can provide useful 
information in differentiating some shoulder disorders such as AC and RC tendinopathy. For 
example, AC is reported to be associated with limitation in both active and passive ROM, while 
RC tendinopathy is usually associated with limitations in only active ROM [33].  
Several clinical special and strength tests are often used to diagnose shoulder pathology. 
However, one test is not interpreted in isolation but is clustered with additional clinical findings 
when establishing a clear diagnosis for shoulder problems. Examples of these tests include 
Hawkins' test and Neer's sign to help in diagnosing shoulder impingement syndromes; Drop-
arm test, Lift-off test and Empty Can test are strength tests that indicate a defect in the RC; 
Apprehension and Relocation tests to diagnose anterior shoulder instability; and Yergason's 
test and Speed's maneuver to assist in the diagnosis of biceps tendon instability or tendonitis 
[32,33].  
Several self- and examiner-reported outcome measures tools have been validated to assist in 
the examination of shoulder pain and function. These measures include the Visual Analogue 
Scale (VAS) for pain assessment, and measures of shoulder function and disability such as the 
Shoulder Pain and Disability Index (SPADI), Constant Shoulder Score (CSS), American 
Shoulder and Elbow Surgeons (ASES), Disabilities of the Arm, Shoulder, and Hand (DASH; 
Quick DASH), and Simple Shoulder Test (SST) questionnaires. All of these questionnaires 
have been shown to be valid and reliable for the  assessment of shoulder function in various 
clinical situations [34].  
Lastly, there are several imaging tests to confirm the diagnosis of shoulder joint pathology 
including plain x-ray to diagnose bone abnormalities such as osteoarthritis, ultrasound which 
may be used to diagnose rotator cuff pathology, and magnetic resonance imaging (MRI) and 
computerized tomography scan (CT), which are used to diagnose bone and soft tissue 
abnormalities [32].  
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 1.1.5 Management of shoulder disorders  
 
As mentioned earlier, obtaining a complete patient history and performing a thorough physical 
examination are essential in determining proper means of treatment for different shoulder 
disorders. Several studies have examined the effectiveness of surgical and non-surgical 
treatment interventions for managing shoulder disorders such as AC, RC tendinopathy, 
arthritis, and shoulder instability. The non-surgical interventions may include 
physiotherapeutic interventions, pain-control medications, and steroid injection. Examples of 
surgical approaches include shoulder arthroscopy and shoulder arthroplasty.      
 1.1.5.1 Non-surgical interventions  
 
The most common shoulder disorders that might be treated by non-surgical interventions are 
AC, RC tendinopathy, mild to moderate shoulder OA, and shoulder instability. It is generally 
recommended to start with a non-surgical treatment for managing these disorders when pain 
and functional limitation are modest. Surgical interventions may be considered for patients 
who remain functionally disabled in spite of appropriate non-surgical treatment [33,35]. 
Physical therapy interventions have been shown to benefit patients with different shoulder 
conditions. For example, low-level laser therapy was found to reduce pain and improve 
function in patients with AC [36]. In addition, deep and superficial heat modalities have been 
reported to provide short-term pain relief and improve ROM for patients with AC;  however, 
the use of US for reduce pain and improve function is not recommended [36]. Active ROM 
exercises, self-stretching and joint mobilization techniques have been reported by several 
systematic reviews to reduce pain and restore shoulder ROM and function in patients with AC 
[36–39]. Further, gentle ROM and isometric strengthening of the rotator cuff and scapulothoracic 
muscles are effective in reducing pain and improving shoulder ROM in patients with mild to 
moderate shoulder OA with no evidence of atrophy or contracture [6].   
Physical therapy programs that emphasize progressive strengthening of the rotator cuff, 
deltoid, and scapulothoracic muscles combined with functional exercises that require 
coordination among multiple muscle groups have been commonly recommended for treating 
patients with shoulder instability. These exercises are reported to control glenohumeral joint 
translation, improve shoulder joint stability, and reduce anterior glenohumeral ligamentous 
strain especially during arm elevation [40]. In addition, for post-traumatic shoulder instability, 
a weak evidence supports the use of ROM and strengthening exercises [35].  
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The effectiveness of exercise therapy for the treatment of RC tendinopathy/impingement has 
been investigated in several systematic reviews [41–44]. Data from these reviews strongly suggest 
that therapeutic exercises combined with manual therapy produce statistically and clinically 
significant reductions in pain and improvement in shoulder ROM. In addition, exercise therapy 
may be effective at improving shoulder function. This effect may be augmented with 
acromioplasty and joint mobilization techniques [41–44]. However, a moderate-quality evidence 
(on GRADE scale) indicates that subacromial decompression provides no improvement in 
shoulder pain and function for the treatment of RC tendinopathy [45].  
A typical physical therapy program may include pendulum exercise, active assisted and active 
ROM exercises, postural exercises, scapular stabilization exercises, stretching exercises, joint 
mobilization techniques, and soft tissue mobilization techniques. However, none of these 
systematic reviews described the specific components of the exercise protocols (type, intensity, 
duration and frequency) that are associated with best outcomes [41–44]. 
Intra-articular steroid injections are commonly used for patients with shoulder pain. There is 
moderate evidence that supports small short-term pain reduction in patients with AC following 
steroid injection [36–38,46]. Further, steroid injections provide superior improvements in shoulder 
pain for patients with RC impingement when compared to no injection controls, and ultrasound 
guided injections are superior to non-guided injections [41]. Furthermore, corticosteroid 
injections seem to relieve shoulder pain in patients with shoulder OA [6,47]. 
 1.1.5.2 Surgical interventions  
 
In patients with persistent shoulder pain and dysfunction despite conservative treatments, 
surgery may be indicated to relieve pain and restore joint function. A number of different 
surgical approaches to manage shoulder disorders have been reported in the orthopedic 
literature including shoulder arthroscopy and shoulder arthroplasty.  
Shoulder arthroscopy is performed by inserting an arthroscope into the joint through a small 
incision. This minimally invasive surgical procedure allows for an examination and treatment 
of various joint pathologies. For patients with AC, a diagnostic arthroscopy is performed to 
confirm the diagnosis followed by release and excision of fibrotic structures such as the rotator 
interval, the middle glenohumeral ligament and the axillary pouch. Two systemic reviews  have 
reported that this procedure improves shoulder ROM and function and is an effective treatment 
for AC [46,48]. However, confidence in these findings is a concern due to poor methodological 
quality of the included studies [46,48].  
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Further, arthroscopic treatment of RC tendinopathy has been shown to significantly improve 
shoulder symptoms and function treated using different arthroscopic approaches such as 
debridement of the tear with or without acromioplasty, trans-tendon repair, or conversion of 
the lesion to full thickness tear followed by repair [49].  
Shoulder arthroplasty is a common surgical procedure in which all or part of the shoulder joint 
is replaced by a prosthetic implant to alleviate shoulder pain and restore joint function [50]. 
Shoulder arthroplasty, which was pioneered by Gluck and Péan in the 1800s to treat 
tuberculous arthritis of the shoulder, failed miserably, and the procedure was eventually 
revisited by Neer in the 1950s for the treatment of proximal humeral fractures. Recent 
advancements in prosthesis design have resulted in expanded indications and a concomitant 
increase in the rates for shoulder arthroplasty [51,52] 
Currently, end-stage primary glenohumeral osteoarthritis is the primary diagnosis for 77% of 
shoulder arthroplasty and often occurs more frequently among adults aged 65 years or older 
[53]. This surgical procedure is usually indicated when conservative treatments such as 
therapeutic exercises and manual therapy techniques fail [53].  
There are three main types of shoulder arthroplasty: total shoulder arthroplasty (TSA), 
hemiarthroplasty (HA), and reverse total shoulder arthroplasty (rTSA). TSA involves replacing 
both the humeral head and the glenoid fossa, while HA involves replacing only the humeral 
head with metal implants. However, in rTSA, the surgeon replaces the anatomical humeral 
head with a plastic socket and replaces the anatomical socket of the scapula with a metal ball. 
Patients with OA and an intact or reparable rotator cuff typically undergo TSA, while patients 
with OA and an irreparable rotator cuff tear traditionally undergo rTSA or HA [54]. However, 
TSA has been reported to result in greater improvement in shoulder ROM and pain, and in less 
need for surgery revision when compared to HA [51].   
The main indication for rTSA is shoulder OA with irreparable rotator cuff tear when 
conventional surgery fails. However, the advancement of the prosthetic design has led to 
expansion of the indications to include any condition about the shoulder where rotator cuff 
function is deficient including RA and proximal humeral fractures [55].  
Despite the improvements of shoulder function and pain after shoulder arthroplasty, shoulder 
arthroplasty is not without complications. Shoulder subluxation or dislocation, periprosthetic 
fracture, and joint infection are the most commonly reported postoperative complications [50,56]. 
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Additional complications that are specific to rTSA may include glenoid loosening, 
musculocutaneous nerve palsy, and acromial fractures [55]. 
 1.1.6 Impact of diabetes on shoulder recovery  
 
All the above-mentioned interventions have been evaluated in generic populations and have 
been shown to be effective in reducing shoulder pain and improving ROM and function. 
However, patients with shoulder disorders and concurrent comorbidities such as diabetes have 
been reported to respond less favorably to these interventions. Indeed, a recent systematic 
review evaluated the effectiveness of non-surgical interventions for managing AC in patients 
with diabetes [57]. The authors reported that low quality evidence suggests large effects of joint 
mobilization plus exercises on AC in people with diabetes and even weaker support was 
available for corticosteroid and manipulation under anesthesia (MUA) [57]. 
Vastamaki et al. followed-up patients with and without diabetes who have AC for the duration 
of 10 years. Although shoulder ROM improved over time in patients with diabetes, this 
improvement was inferior to patients without diabetes and remained below normal ROM [58]. 
Further, Juel et al. and Larkin et al. have also shown that patients with type 1 diabetes develop 
long-lasting shoulder stiffness, functional disability and reduced ROM than patients without 
diabetes. These studies suggested that early shoulder assessment and treatment may be needed 
to reduce disability and improve quality of life of patients with diabetes  [23,24].  
Furthermore, in longitudinal cohort studies, Rill et al. evaluated the effect of operative and 
nonoperative treatments on AC using the SST questionnaire, while Cole et al. evaluated the 
association between diabetes and shoulder complaints using the SPADI questionnaire. Both 
studies reported higher shoulder pain, reduced mobility, poor functional outcomes, reduced 
quality of life, and a diminished response to treatment in patients with  diabetes who have AC 
than patients without diabetes [59,60].  
Studies that evaluated the impact of diabetes on shoulder recovery following arthroscopic 
rotator cuff repair have reported an inferior improvement in shoulder pain and function in 
patients with diabetes, in addition to an increased risk of anatomic failure of the repaired rotator 
cuff tendon especially in patients with uncontrolled hyperglycemia [61,62].  
Diabetes has been shown to be an independent risk factor for increased risk of non-home 
discharge (Odds ratio (OR): 1.3), and longer hospital stays (OR: 1.4) following shoulder 
arthroplasty [63,64]. Further, diabetes, along with hypertension and obesity, are associated with 
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postoperative complications such as humeral fracture and joint infection [65]. However, the 
impact of diabetes on functional outcomes and motion after shoulder arthroplasty has not yet 
been investigated. 
1.1.7 Summary of limitations in current knowledge 
 
Studies consistently report that patients with diabetes are more frequently affected by AC, have 
long lasting symptoms and a poorer prognosis than patients without diabetes [11,22–25,66]. Further, 
although some of the therapeutic interventions have been shown to be effective in managing 
primary AC, several studies have reported higher shoulder pain, reduced mobility, poor 
functional outcomes, reduced quality of life, and a diminished response to treatment in patients 
with diabetes than patients without diabetes [23,24,59,60]. There is lack of systematic reviews to 
assess the effectiveness of therapeutic interventions in managing AC in patients with diabetes 
and to show whether the current recommendations for treatment of AC can be equally applied 
to patients with diabetes.  
There have been efforts to define an optimal physical therapy protocol for managing AC in 
patients with diabetes. The usual approach to AC includes mobilization of soft tissues and 
implementation of shoulder exercises to restore function. However, recovery is slow and often 
incomplete, especially for people with diabetes. Aerobic exercises can improve hyperglycemia 
and insulin sensitivity in skeletal musculature [67], which may have a greater impact on the AC 
pathophysiology. To the author's knowledge, an optimal physical therapy protocol for 
managing AC in patients with diabetes is not defined.  
Given the fact that hyperglycemia has a negative impact on body tissue [17], and the adverse 
effect of diabetes on postoperative complications and hospital stays [63,65], there is a need to 
investigate whether diabetes affects functional outcomes after shoulder arthroplasty. To the 
author's knowledge, no study has evaluated the impact of diabetes on shoulder pain and 
function following shoulder arthroplasty.  
There are limited studies that have addressed the factors which influence postoperative 
functional outcomes following shoulder arthroplasty. Identifying preoperative factors that are 
predictive of one-year outcomes could assist surgeons and health care providers in providing 
patients with more realistic expectations on outcomes and may help plan postoperative pain 
management and rehabilitation. To the author's knowledge, factors that predict the clinical 
benefits following shoulder arthroplasty have not been thoroughly investigated.   
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1.1.8 Future directions  
 
There is a need to conduct systematic reviews to determine the effectiveness of non-surgical 
interventions (steroid injections, physiotherapeutic interventions, and MUA) and surgical 
interventions (arthroscopy and arthroplasty) on shoulder pain, function, and ROM for 
managing AC in people with diabetes. Further, clinical researchers need to run more robust 
randomized trials to examine the impact of these therapeutic interventions on shoulder function 
in patients with diabetes as compared to patients without diabetes.  Furthermore, studies are 
required to investigate the impact of diabetes on pain, patient-reported function, and 
impairments in shoulder ROM and muscle strength in patients who underwent shoulder 
arthroplasty. Lastly, further research is recommended to investigate whether factors such as 
comorbidities and demographics predict patient-reported outcomes including shoulder pain 
and function and clinical benefits following shoulder arthroplasty  
In summary, studies to examine the effectiveness of different surgical and non-surgical 
interventions on managing shoulder disorders in patients with diabetes are required. In 
addition, more research is required to investigate the impact of diabetes on shoulder recovery, 
and factors predicting shoulder function following shoulder arthroplasty.  
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1.2 Purpose of this thesis 
 
The two purposes of this thesis were to inform physical therapy management of 1) patients 
with diabetes who have AC and 2) patients with diabetes who are recovering from shoulder 
arthroplasty. We have the following objectives:  
- To conduct a systematic review that determine the effectiveness of non-surgical 
interventions [steroid injections, physiotherapeutic interventions (joint mobilization, 
laser therapy, continuous passive motion, electrotherapy, reflexology, therapeutic 
exercises) and MUA] on shoulder pain, function, and ROM for managing AC in people 
with diabetes. 
- To run a pilot randomized trial that compares the effect of a regular physiotherapy (PT) 
program to a regular PT combined with a progressive walking program (PT+) in 
patients with and without diabetes who have AC. This pilot trial will also evaluate the 
feasibility of recruitment, randomization, retention, assessment procedures, and 
implementation of the novel intervention. Data from this pilot trial will be used to 
calculate an accurate sample size for a full-scale RCT. The secondary objective was to 
determine if diabetes affects response to treatment. 
- To investigate the impact of diabetes on pain, patient-reported function, and 
impairments in shoulder ROM and muscle strength in patients who underwent shoulder 
arthroplasty.  
- To examine whether age, sex, diabetes, hypertension, and depression predict patient-
reported outcomes including shoulder pain and function one year following shoulder 
arthroplasty; if these factors predict the clinical benefits following surgery as reflected 
in the change of outcome scores; and if residual pain (pain at one-year) is associated 
with poorer functional outcomes.   
1.3 Overview of thesis chapters 
 
This thesis focuses on understanding the impact of diabetes on shoulder disorders. This work 
addresses a gap in the literature since remarkably few studies have focused on managing AC 
and shoulder recovery after arthroplasty in patients with diabetes. This work is completed as a 
manuscript thesis where following chapter one which reviews the relevant literature, a series 
of inter-related manuscripts are presented in individual chapters. 
In chapter 2, we have conducted a systematic review where we have reviewed the quality and 
content of clinical research addressing the effectiveness of non-surgical interventions including 
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physiotherapeutic interventions, steroid injections, and manipulation under anesthesia for 
managing AC in patients with diabetes.  
In chapter 3, we have included a pilot study which compared the effect of a regular 
physiotherapy (PT) program to a regular PT combined with a progressive walking program 
(PT+) in patients with and without diabetes who have AC.  
Chapter 4 is a cohort study that evaluated the following research question: Does diabetes affect 
functional outcomes after shoulder arthroplasty? 
Chapter 5 is a cohort study that examined factors predicting shoulder function and clinical 
benefits one-year following shoulder arthroplasty.  
The final chapter provides a general discussion and formulated conclusions based upon the 
previous research, including the most significant findings. We have also provided future 
research directions and recommendations.  
 
 
  
 21 
1.4 References  
 
1.  Kisner C, Colby LA, Borstad J. The shoulder and Shoulder Girdle. In: C. Kisner, L. A. 
Colby & JB, editor. Therapeutic Exercsie: Foundations and Techniques. Philadelphia, 
PA: Fa Davis; 2018. page 546–622. 
2.  Terry GC, Chopp TM. Functional anatomy of the shoulder. J Athl Train 
2000;35(3):248.  
3.  Lippitt SB, Vanderhooft JE, Harris SL, Sidles JA, Harryman II DT, Matsen III FA. 
Glenohumeral stability from concavity-compression: a quantitative analysis. J 
Shoulder Elb Surg 1993;2(1):27–35.  
4.  Rodosky MW, Harner CD, Fu FH. The role of the long head of the biceps muscle and 
superior glenoid labrum in anterior stability of the shoulder. Am J Sports Med 
1994;22(1):121–30.  
5.  Beim GM. Acromioclavicular joint injuries. J Athl Train 2000;35(3):261.  
6.  Chillemi C, Franceschini V. Shoulder osteoarthritis. Arthritis 2013;2013:7.  
7.  Millett PJ, Gobezie R, Boykin RE. Shoulder osteoarthritis: diagnosis and management. 
Am Fam Physician 2008;78(5):605–11.  
8.  Chen AL, Joseph TN, Zuckerman JD. Rheumatoid arthritis of the shoulder. JAAOS-
Journal Am Acad Orthop Surg 2003;11(1):12–24.  
9.  Seitz AL, McClure PW, Finucane S, Boardman III ND, Michener LA. Mechanisms of 
rotator cuff tendinopathy: intrinsic, extrinsic, or both? Clin Biomech 2011;26(1):1–12.  
10.  Neer CS. Impingement lesions. Clin Orthop Relat Res 1983;173:70–7.  
11.  Hsu CL, Sheu WHH. Diabetes and shoulder disorders. J Diabetes Investig 
2016;7(5):649–51.  
12.  Huang Y, Fann C, Chiu Y, Yen M, Chen L, Chen H, et al. Association of diabetes 
mellitus with the risk of developing adhesive capsulitis of the shoulder: a longitudinal 
population‐based followup study. Arthritis Care Res (Hoboken) 2013;65(7):1197–202.  
13.  Bunker TD. Frozen shoulder : unravelling the enigma. Ann R Coll Surg Engl 
1997;79:210–3.  
 22 
14.  Wong CK, Levine WN, Deo K, Kesting RS, Mercer EA, Schram GA, et al. Natural 
history of frozen shoulder: fact or fiction? A systematic review. Physiotherapy 
2017;103(1):40–7.  
15.  Ryan V, Brown H, Lowe CJM, Lewis JS. The pathophysiology associated with 
primary (idiopathic) frozen shoulder: A systematic review. BMC Musculoskelet 
Disord 2016;17(1):340.  
16.  Chen CS. Mechanotransduction–a field pulling together? J Cell Sci 
2008;121(20):3285–92.  
17.  Abate M, Schiavone C, Pelotti P, Salini V. Limited joint mobility in diabetes and 
ageing: recent advances in pathogenesis and therapy. Int J Immunopathol Pharmacol 
2010;23(4):997–1003.  
18.  International diabetes federation. IDF Diabetes Atlas, 2th ed. 2003; 
19.  Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho 
NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 
and 2040. Diabetes Res Clin Pract 2017;128:40–50.  
20.  Dyck R, Osgood N, Lin TH, Gao A, Stang MR. Epidemiology of diabetes mellitus 
among First Nations and non-First Nations adults. Cmaj 2010;182(3):249–56.  
21.  Bridgman JF. Periarthritis of the shoulder and diabetes mellitus. Ann Rheum Dis 
1972;31(1):69.  
22.  Arkkila PET, Gautier J-F. Musculoskeletal disorders in diabetes mellitus: an update. 
Best Pract Res Clin Rheumatol 2003;17(6):945–70.  
23.  Juel NG, Brox JI, Brunborg C, Holte KB, Berg TJ. Very high prevalence of frozen 
shoulder in patients with type 1 diabetes of≥ 45 years’ duration: the Dialong Shoulder 
Study. Arch Phys Med Rehabil 2017;98(8):1551–9.  
24.  Larkin ME, Barnie A, Braffett BH, Cleary PA, Diminick L, Harth J, et al. 
Musculoskeletal complications in type 1 diabetes. Diabetes Care 2014;37(7):1863–9.  
25.  Zreik NH, Malik RA, Charalambous CP. Adhesive capsulitis of the shoulder and 
diabetes: a meta-analysis of prevalence. Muscles Ligaments Tendons J 2016;6(1):26–
34.  
 23 
26.  Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of 
the hand and shoulder in patients with diabetes mellitus. Am J Med 2002;112(6):487–
90.  
27.  Rechardt M, Shiri R, Karppinen J, Jula A, Heliövaara M, Viikari-Juntura E. Lifestyle 
and metabolic factors in relation to shoulder pain and rotator cuff tendinitis: a 
population-based study. BMC Musculoskelet Disord 2010;11(1):165.  
28.  Tauro JC. Stiffness and rotator cuff tears: incidence, arthroscopic findings, and 
treatment results. Arthrosc J Arthrosc Relat Surg 2006;22(6):581–6.  
29.  Handa A, Gotoh M, Hamada K, Yanagisawa K, Yamazaki H, Nakamura M, et al. 
Vascular endothelial growth factor 121 and 165 in the subacromial bursa are involved 
in shoulder joint contracture in type II diabetics with rotator cuff disease. J Orthop Res 
2003;21(6):1138–44.  
30.  Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: 
Sparking the development of diabetic vascular injury. Circulation 2006;114(6):597–
605.  
31.  Whelton C, Peach CA. Review of diabetic frozen shoulder. Eur J Orthop Surg 
Traumatol 2018;28(3):363–71.  
32.  Stevenson JH, Trojian T. Evaluation of shoulder pain. J Fam Pract 2002;51(7):605–11.  
33.  Andrews JR. Diagnosis and treatment of chronic painful shoulder: review of 
nonsurgical interventions. Arthrosc J Arthrosc Relat Surg 2005;21(3):333–47.  
34.  Angst F, Schwyzer H, Aeschlimann A, Simmen BR, Goldhahn J. Measures of adult 
shoulder function: Disabilities of the arm, shoulder, and hand questionnaire (DASH) 
and its short version (QuickDASH), shoulder pain and disability index (SPADI), 
American shoulder and elbow surgeons (ASES) society standardized shoulder. 
Arthritis Care Res (Hoboken) 2011;63(S11):S174–88.  
35.  Gibson K, Growse A, Korda L, Wray E, MacDermid JC. The effectiveness of 
rehabilitation for nonoperative management of shoulder instability: a systematic 
review. J Hand Ther 2004;17(2):229–42.  
36.  Jain TK, Sharma NK. The effectiveness of physiotherapeutic interventions in 
treatment of frozen shoulder / adhesive capsulitis : A systematic review. J Back 
 24 
Musculoskelet Rehabil 2014;27:247–73.  
37.  Blanchard V, Barr S, Cerisola FL. The effectiveness of corticosteroid injections 
compared with physiotherapeutic interventions for adhesive capsulitis: a systematic 
review. Physiotherapy 2010;96(2):95–107.  
38.  Favejee MM, Huisstede BMA, Koes BW. Frozen shoulder: the effectiveness of 
conservative and surgical interventions-systematic review. Br J Sports Med 
2011;45(1):49–56.  
39.  Maund E, Craig D, Suekarran S, Neilson AR, Wright K, Brealey S, et al. Management 
of frozen shoulder: a systematic review and cost-effectiveness analysis. Health 
Technol Assess 2012;16(11):1–264.  
40.  Hayes K, Callanan M, Walton J, Paxinos A, Murrell GAC. Shoulder instability: 
management and rehabilitation. J Orthop Sport Phys Ther 2002;32(10):497–509.  
41.  Steuri R, Sattelmayer M, Elsig S, Kolly C, Tal A, Taeymans J, et al. Effectiveness of 
conservative interventions including exercise, manual therapy and medical 
management in adults with shoulder impingement: a systematic review and meta-
analysis of RCTs. Br J Sports Med 2017;51(18):1340–7.  
42.  Kuhn JE. Exercise in the treatment of rotator cuff impingement: A systematic review 
and a synthesized evidence-based rehabilitation protocol. J Shoulder Elb Surg 
2009;18(1):138–60.  
43.  Desmeules F, Boudreault J, Dionne CE, Frémont P, Lowry V, MacDermid JC, et al. 
Efficacy of exercise therapy in workers with rotator cuff tendinopathy: a systematic 
review. J Occup Health 2016;15–103.  
44.  Hanratty CE, McVeigh JG, Kerr DP, Basford JR, Finch MB, Pendleton A, et al. The 
effectiveness of physiotherapy exercises in subacromial impingement syndrome: a 
systematic review and meta-analysis. In: Seminars in arthritis and rheumatism. 
Elsevier; 2012. page 297–316. 
45.  Karjalainen T V, Jain NB, Page CM, Lähdeoja TA, Johnston R V, Salamh P, et al. 
Subacromial decompression surgery for rotator cuff disease. Cochrane Database Syst 
Rev 2019;(1).  
46.  Uppal HS, Evans JP, Smith C. Frozen shoulder: A systematic review of therapeutic 
 25 
options. World J Orthop 2015;6(2):263–8.  
47.  Colen S, Geervliet P, Haverkamp D, Van Den Bekerom MPJ. Intra-articular 
infiltration therapy for patients with glenohumeral osteoarthritis:  A systematic review 
of the literature. Int J Shoulder Surg 2014;8(4):114–21.  
48.  Grant JA, Schroeder N, Miller BS, Carpenter JE. Comparison of manipulation and 
arthroscopic capsular release for adhesive capsulitis: a systematic review. J shoulder 
Elb Surg 2013;22(8):1135–45.  
49.  Strauss EJ, Salata MJ, Kercher J, Barker JU, McGill K, Bach Jr. BR, et al. The 
arthroscopic management of partial-thickness rotator cuff tears: A systematic review 
of the literature. Arthroscopy 2011;27(4):568–80.  
50.  Deshmukh A V, Koris M, Zurakowski D, Thornhill TS. Total shoulder arthroplasty: 
long-term survivorship, functional outcome, and quality of life. J Shoulder Elb Surg 
2005;14(5):471–9.  
51.  van den Bekerom MPJ, Geervliet PC, Somford MP, van den Borne MPJ, Boer R. Total 
shoulder arthroplasty versus hemiarthroplasty for glenohumeral arthritis: A  systematic 
review of the literature at long-term follow-up. Int J Shoulder Surg 2013;7(3):110–5.  
52.  Bankes MJK, Emery RJH. Pioneers of shoulder replacement: themistocles Gluck and 
Jules Emile Péan. J shoulder Elb Surg 1995;4(4):259–62.  
53.  Kim SH, Wise BL, Zhang Y, Szabo RM. Increasing incidence of shoulder arthroplasty 
in the United States. JBJS 2011;93(24):2249–54.  
54.  Singh JA, Sperling J, Buchbinder R, McMaken K. Surgery for Shoulder Osteoarthritis: 
A Cochrane Systematic Review. J Rheumatol 2011;38(4):598–605.  
55.  Smith CD, Guyver P, Bunker TD. Indications for reverse shoulder replacement. J 
Bone Joint Surg Br 2012;94-B(5):577–83.  
56.  Norris TR, Iannotti JP. Functional outcome after shoulder arthroplasty for primary 
osteoarthritis: a multicenter study. J Shoulder Elb Surg 2002;11(2):130–5.  
57.  Alsubheen S, Nazari G, Bobos P, MacDermid JC, Overend TJ, Faber K. Effectiveness 
of nonsurgical interventions for managing adhesive capsulitis in patients with diabetes: 
A systematic review. Arch Phys Med Rehabil 2019;100(2):350–65.  
 26 
58.  Vastamäki H, Ristolainen L, Vastamäki M. Range of motion of diabetic frozen 
shoulder recovers to the contralateral level. J Int Med Res 2016;44(6):1191–9.  
59.  Cole A, Gill TK, Shanahan EM, Phillips P, Taylor AW, Hill CL. Is diabetes associated 
with shoulder pain or stiffness? Results from a population based study. J Rheumatol 
2009;36(2):371–7.  
60.  Rill BK, Fleckenstein CM, Levy MS, Nagesh V, Hasan SS. Predictors of outcome 
after nonoperative and operative treatment of adhesive capsulitis. Am J Sports Med 
2011;39(3):567–74.  
61.  Clement ND, Hallett A, MacDonald D, Howie C, McBirnie J. Does diabetes affect 
outcome after arthroscopic repair of the rotator cuff? J Bone Joint Surg Br 2010;92-
B(8):1112–7.  
62.  Cho NS, Moon SC, Jeon JW, Rhee YG. The Influence of Diabetes Mellitus on Clinical 
and Structural Outcomes After Arthroscopic Rotator Cuff Repair. Am J Sports Med 
2015;43(4):991–7.  
63.  Mahure SA, Quien MM, Karia R, Zuckerman JD, Kwon YW. Impact of diabetes on 
perioperative complications in patients undergoing elective total shoulder arthroplasty. 
Bull NYU Hosp Jt Dis 2017;75(3):173–80.  
64.  Ponce BA, Menendez ME, Oladeji LO, Soldado F. Diabetes as a risk factor for poorer 
early postoperative outcomes after shoulder arthroplasty. J Shoulder Elb Surg 
2014;23(5):671–8.  
65.  Jain NB, Guller U, Pietrobon R, Bond TK, Higgins LD. Comorbidities increase 
complication rates in patients having arthroplasty. Clin Orthop Relat Res 
2005;435:232–8.  
66.  Hand C, Clipsham K, Rees JL, Carr AJ. Long-term outcome of frozen shoulder. J 
Shoulder Elb Surg 2008;17(2):231–6.  
67.  Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, et al. 
Exercise training for type 2 diabetes mellitus. Circulation 2009;119(25):3244–62.  
 
 
 27 
 
 
 
CHAPTER 2: 
 
EFFECTIVENESS OF NON-SURGICAL INTERVENTIONS 
FOR MANAGING ADHESIVE CAPSULITIS IN PATIENTS 
WITH DIABETES:  A SYSTEMATIC REVIEW 
 
 
 
A form of this manuscript is published in the Archives of Physical Medicine and 
Rehabilitation  
 
Citation:  
 
Alsubheen, S. A., Nazari, G., Bobos, P., MacDermid, J. C., Overend, T. J., & Faber, K. J., 
(2019). Effectiveness of nonsurgical interventions for managing adhesive capsulitis in 
patients with diabetes: A systematic review. Archives of Physical Medicine and 
Rehabilitation, 100(2), 350-365. 
  
 28 
Abstract 
 
Objective: This systematic review evaluated the effectiveness of non-surgical interventions 
for managing adhesive capsulitis (AC) in patients with diabetes on pain, function and range of 
motion.  
Data Sources: MEDLINE and other databases were searched for studies published in the last 
20 years.  
Study Selection: Randomized clinical trials (RCTs) that assessed adhesive capsulitis in people 
with diabetes and implemented one or a combination of physiotherapeutic interventions, 
corticosteroids, and manipulation under anesthesia (MUA) were eligible for inclusion.  
Data Extraction: The Cochrane Risk of Bias was used by two independent raters who met to 
achieve consensus. The quality of trials was assessed using Grading of Recommendations, 
Assessment, Development and Evaluations (GRADE). Data extracted from the eligible studies 
included study design, subject characteristics, duration of symptoms, type of intervention, 
outcome measures, follow-up intervals and research findings. 
Data Synthesis: Due to the lack of similar interventions, a narrative synthesis was conducted, 
and meta-analyses were not performed. The effect sizes or between-group differences of the 
interventions were reported. A total of eight RCTs met the inclusion criteria: four addressed 
physiotherapeutic interventions, three corticosteroid injections and one MUA. The effect sizes 
for physiotherapeutic interventions were 0.8-2.0, 0.9-2.0, and 1.0 for ROM, function and pain 
respectively, with the largest effect size (2.0) being reported for joint mobilization plus 
exercises. The effect sizes for corticosteroids were 0.2-0.5 and 0.1 for ROM and pain. The 
between-group improvement for MUA was 5.6 points on Constant Shoulder Score. 
Conclusion:  Low quality evidence suggests large effects of joint mobilization plus exercises 
on adhesive capsulitis in people with diabetes, although confidence in this conclusion is limited 
due to at the high risk of bias. Even weaker support was available for corticosteroid and MUA. 
Future high quality RCTs are needed to determine the best intervention for managing AC in 
patients with diabetes. 
Systematic review registration #: CRD42018084090 on PROSPERO 
(https://www.crd.york.ac.uk/PROSPERO) 
 
Keywords: Adhesive capsulitis, Corticosteroids, Diabetes, Physiotherapy, Systematic review 
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2.1 Background  
 
2.1.1 Description of the condition 
  
Adhesive capsulitis (AC), also known as frozen shoulder, is a common shoulder disorder that 
is characterized by a  progressive and painful restriction of range of motion (ROM), that results 
in functional disability [1]. The condition is more common in people with diabetes with an 
estimated prevalence of 10-76% in type 1 and 7-30% in type 2 diabetes as compared to 0-10% 
in the general population [2–5]. Adhesive capsulitis is more frequent in women [6] and is 
associated with age in both types of diabetes [5] and with the duration in type 1 diabetes [2,3,7]. 
Further, poor glycemic control has been shown to worsen shoulder pain and function in people 
with type 1 diabetes [2,3].   
Primary or idiopathic AC has no clear underlying cause and secondary AC is associated with 
a known systematic cause such as diabetes. The pathophysiology of primary AC is poorly 
understood but could occur as a result of inflammatory or fibrosing processes [8]. However, the 
glycosylation of collagen fibers of the joint capsule and the impaired circulation of the joint 
small capillaries have been proposed as potential mechanisms that might explain the 
pathological process in patients with diabetes [1].  
For many years, AC has been described as a self-limited condition that progresses through a 
natural history of painful, frozen and thawing phases, leading to full recovery without 
treatment. However, a recent systematic review assessed the quality of the evidence that has 
characterizes AC into three phases and that supports the concept that full recovery occurs 
without treatment [9]. The authors reported a lack of evidence to support the theortical phases 
of AC. In addition, this review found that moderate-quality evidence supported an early 
improvement in shoulder ROM and function that slows over time and leads to long-term 
limitations which questions the common perception that AC is a self-limited condition. Further, 
they reported that low-quality evidence  suggested  incomplete improvement in ROM after one 
to four years of follow-up [9]. The authors recommended that  the theory of natural progression 
of AC should be removed from professional and public information sites  since it is  not 
supported and potentially misleading.  They also noted the need for future research towards 
diagnostic processes to identify the underlying causes of stiffness and disability of patients 
with AC [9].   
 
2.1.2 Description of the therapeutic interventions  
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The diagnostic criteria of AC such as the global loss of shoulder ROM and night pain have 
been proposed by several experts [10]. However, these clinical criteria were not found to be 
valid diagnostic signs of AC due to the lack of information about the first 3-6 months of this 
disorder [9,10]. Thus, there is uncertainty about AC diagnosis and  natural history [9]. The lack 
of understanding of  early AC  suggests that  appropriate early treatment might be needed to 
avoid long-term functional limitations and disability [9].  
Although studies [11] evaluating the supervised-neglect approach have shown to yield better 
outcomes than passive mobilization and stretching in patients with AC, the improvement in the 
supervised-neglect group cannot strictly be considered as the natural gentle thawing of the 
condition because patients were instructed to do pendulum and active exercises within the 
painless ROM which constitutes a home exercise program that is expected to provide 
therapeutic benefits [11]. Furthermore, Diercks et al.  excluded patients with diabetes from their 
study because of concerns that the disorder behaved differently in this population subset [11]. 
Therefore, the supervised-neglect approach may not be applicable for patients with diabetes.  
Vastamaki et al. followed-up patients with and without diabetes who have AC for the duration 
of 10 years [12]. Although shoulder ROM improved over time in patients with diabetes, the 
improvement was inferior to patients without diabetes and remained below normal ROM [12]. 
Other studies have also shown that patients with type 1 diabetes develop long-lasting shoulder 
stiffness, functional disability and reduced ROM than patients without diabetes [2,3]. These 
studies suggested the need to start early shoulder assessment and treatment to reduce disability 
and improve quality of life of patients with diabetes [2,3]. Lastly, Wong et al. showed that 
moderate to strong evidence supports early treatment interventions to reduce pain and improve 
ROM and function compared to the low evidence that supports a “no treatment” approach [9].  
Several systematic reviews have examined the effectiveness of different treatment approaches 
for AC  in  generic populations, i.e. not specifically people with diabetes [13–18]. Moderate 
evidence showed small short-term benefits of steroid injection in reducing pain [13,14,16,18], while 
some physiotherapeutic interventions such as exercises and joint mobilization have been shown 
to reduce pain, restore shoulder ROM and function in both short and long-term [13,14,16,17]. Low 
to moderate evidence was found for the effectiveness of acupuncture on pain and ROM [14,16]. 
Furthermore, a recent randomized trial reported that acupuncture relieved pain and restored 
shoulder function in patients with frozen shoulder [19]. Studies of MUA and surgical capsular 
release that report clinical benefits unfortunately have poor methodological quality [15,18].  
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2.1.3 Why it is important to conduct this systematic review? 
 
Studies have consistently reported that people with diabetes are more frequently affected by 
AC, have long lasting symptoms and a poor prognosis [20]. Further, although some of the 
therapeutic interventions have been shown to be effective in managing primary AC, several 
studies have reported higher shoulder pain, reduced mobility, poor functional outcomes, 
reduced quality of life, and a diminished response to treatment in patients with diabetes than 
patients without diabetes [2,3,12,21,22]. In addition, none of the aforementioned systematic reviews 
focused on patients with diabetes, or formally tested diabetes as a source of clinical 
heterogeneity in response to treatment. The underlying pathophysiology of AC in patients with 
diabetes may differ from non-diabetics and it is unclear whether existing recommendations for 
the treatment of AC can be equally applied to the subset of patients with diabetes. 
 
2.2 Objectives 
 
To determine the effectiveness of steroid injections, physiotherapeutic interventions (joint 
mobilization, laser therapy, continuous passive motion, electrotherapy, reflexology, 
therapeutic exercises) and MUA on shoulder pain, function, and ROM for managing adhesive 
capsulitis in people with diabetes. 
 
2.3 Methods  
 
2.3.1 Study selection  
 
2.3.1.1 Study design 
Randomized controlled trials published in English or any other language were eligible for 
inclusion in this review.  
 
2.3.1.2 Participants 
Trials that included adult participants aged 18 years or older with a stated diagnosis of AC and 
diabetes (both types) were eligible to be included in this review. Due to lack of a gold standard 
for the diagnosis of AC, trials were included if it was stated that participants had pain and 
restriction in shoulder joint ROM in one or more planes [23]. Studies that included participants 
with other shoulder disorders such as rotator cuff tendinitis or osteoarthritis were not eligible 
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for inclusion. Further, studies that excluded patients with diabetes or included patients with 
diabetes treated in one group with patients without diabetes were also excluded from this 
review unless these studies' authors provided a subgroup analysis of patients with diabetes.   
 
2.3.1.3 Types of interventions  
Trials that randomly implemented one or a combination of the following non-surgical 
interventions were eligible for inclusion in this review: physiotherapeutic interventions, 
corticosteroid injection, MUA, hydrodilatation, and suprascapular nerve block. 
physiotherapeutic interventions could include, but were not limited to, mobilization techniques, 
exercises, electrotherapy, and patient education.  
 
2.3.1.4 Outcome measures  
Studies that assessed at least one outcome measure that is validated and commonly used to 
examine shoulder pain or function were eligible for inclusion. These measures could include 
measures of shoulder pain using Visual Analogue Scale (VAS), measures of ROM using 
standard or electronic goniometer, and measures of shoulder function and disability such as the 
Shoulder Pain and Disability Index (SPADI), Constant Shoulder Score (CSS), American 
Shoulder and Elbow surgeons (ASES) and Simple Shoulder Test (SST) questionnaires. All of 
the questionnaires are valid and reliable to assess shoulder function in different clinical 
situations [24]. However, only the SPADI has specifically been validated for  patients with AC 
[25,26].  
 
2.3.2 Search methods for identification of studies 
 
2.3.2.1 Electronic searches 
To conduct this systematic review, an electronic search of the following databases was 
performed: MEDLINE, Science Direct, Scopus, Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), Cochrane library, EMBASE, Ingenta connect, Sport Discus, 
Physiotherapy Evidence Database (PEDro) and ProQuest. The search of these databases was 
conducted on a university library system during the months of October 2017-January 2018. 
The search was limited to human subjects and articles published within last 20 years. Diabetes 
and the two most common terms used to describe the shoulder condition, "adhesive capsulitis" 
and "frozen shoulder", were combined using the operation "AND" and were used as key terms 
for the search. MEDLINE was searched using a combination of the key terms and the "AND" 
 33 
operation with the following terms: "physiotherapy", "exercise", "manual therapy", "joint 
mobilization", "modalities", electrotherapy", rehabilitation", corticosteroids", "manipulation 
under anesthesia", "arthroscopy", hydrodilatation", and "suprascapular nerve block". The 
MEDLINE search strategy is illustrated in Box 1. 
 
2.3.2.2 Searching other resources 
Reference lists of all relevant articles were scanned in an attempt to identify any further studies. 
We also searched common shoulder and diabetes journals' supplements to identify conference 
abstracts. 
 
2.3.3 Data extraction and management 
  
After scanning the titles and abstracts of the identified studies, duplicate articles or those not 
related to the topic of interest were removed. Studies deemed to be relevant to the review were 
retrieved and assessed for eligibility. Data extraction was performed by two authors and 
included study design, subject characteristics and duration of symptoms, type of intervention, 
outcome measures, follow-up intervals, as well as methods of data analysis and research 
findings (Table 1).  
 
2.3.4 Assessment of risk of bias in included studies 
 
A calibration review was performed by the most experienced researcher (J.M.) and two co-
authors (G.N. and P.B.) performed risk of bias assessments. Pairs of authors (G.N. and P.B.) 
independently applied the quality assessment tool for quantitative studies (Cochrane Risk of 
Bias tool) [27] on the eligible studies, and any disagreement was resolved by J.M. The authors 
followed the usual procedures to use the six domains documented in this tool to assess the risk 
of bias in the eligible studies [27].  
 
2.3.5 Measures of treatment effect  
 
A meta-analysis was considered at the initial plan of this systematic review as described in our 
published protocol on PROSPERO (https://www.crd.york.ac.uk/PROSPERO) (Registration #: 
CRD42018084090). However, due to the wide range of physiotherapeutic interventions (lack 
of similar interventions) assessed across the included studies, a meta-analysis was not 
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performed. To assess the effectiveness of the interventions in the included trials, (i.e. the 
magnitude of the effects), we calculated the between group effect sizes by reporting the 
Standardized Response Mean (SRM) = δᵪ / SDδᵪ [28]. The δᵪ is the mean between-group 
differences, and the SDδᵪ is the pooled standard deviation reflecting the variability of change 
between the two groups [28]. To allow and facilitate clinical decision making, benchmark values 
of trivial (< 0.20), small (≥ 0.20 to < 0.50), moderate (≥ 0.50 to < 0.80) or large (≥ 0.80), 
proposed by Cohen, were utilized [28]. In trials where SRM calculation was not possible (due 
to lack of SD reporting), we calculated and reported the between group mean differences. 
 
2.3.6 Assessing the quality of individual RCTs 
 
We used the Grading of Recommendations, Assessment, Development and Evaluations 
(GRADE) approach for systematic reviews, (GRADE guidelines: 4. Rating the quality of 
evidence – study limitations – risk of bias; GRADE guidelines: 5. Rating the quality of 
evidence – publication bias; GRADE guidelines 6. Rating the quality of evidence – imprecision 
(how precise is the effect size?); GRADE guidelines: 8. Rating the quality of evidence – 
indirectness (difference between the population of interest and those who have participated in 
relevant studies) [29–33], to assess the quality of individual RCTs related to three outcomes; 
shoulder pain, shoulder ROM and measures of shoulder function and disability. The quality 
rating of individual RCTs for each outcome across trials was performed to provide the extent 
of our confidence that the estimates of the effect were correct. The GRADE approach resulted 
in an assessment of the quality of individual RCTs for each outcome across trials as high, 
moderate, low, or very low [29–33]. 
 
2.4 Results 
  
2.4.1 Characteristics of included studies 
 
Our search strategy generated 165 articles on MEDLINE and 650 articles in total (Figure 1). 
After applying the inclusion and exclusion criteria, 10 studies were eligible to be included. Of 
these 10 studies, two studies were excluded because the full study was not published 
(conference abstracts). Eight studies were evaluated and data from these studies were extracted 
and summarized in Table 2. Among these eight studies, two studies were translated from 
Chinese [34] and Persian [35] languages into English language by two native language speakers.  
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All these studies were RCTs that assessed the effectiveness of physiotherapeutic interventions 
(joint mobilization, laser therapy, continuous passive motion, electrotherapy, reflexology, 
therapeutic exercises) [34,36–38], corticosteroid injection [39–41], and MUA [35] used to manage AC 
in patients with diabetes. The eight eligible studies ranged in size from 30–147 patients and 
included a total of 340 patients with diabetes. The main diagnosis was AC, and the mean age 
in studies ranged from 53 to 61 years. The duration of follow up ranged from two weeks to 12 
months. 
 
2.4.2 Risk of Bias Assessment 
 
We completed a risk of bias assessment for each study and illustrated this in Figure 2. The 
main potential source of bias was performance bias in all eight RCTs, as a result of inadequate 
blinding of study participants and personnel [34–41]. Furthermore, seven RCTs were rated at high 
risk of selection bias due to unclear or lack of adequate random sequence generation [34–38] and 
allocation concealment [34,35,37–41]. Six trials demonstrated inadequate blinding of assessors – 
detection bias [34,35,37–39,41]. In addition, five RCTs were rated at high risk of attrition bias 
[34,35,39–41] and four RCTs at high risk of reporting bias [34,35,37,41], due to incomplete outcome 
data and selective reporting respectively.  
 
2.4.3 Interventions 
 
A wide range of non-surgical interventions were evaluated in the included trials: 
1. Mulligan mobilization, pendular exercise and home exercise program vs. Maitland 
mobilization, pendular exercise and home exercise program [38]. 
2. Low-level laser therapy plus stretching exercises vs. Reflexology (thumb walk) plus 
stretching exercises [37]. 
3. Intra-articular corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDS) plus 
home exercise program vs. NSAIDS plus home exercise program [41]. 
4. Triamcinolone acetonide (40 mg) injection and home exercise program vs 
triamcinolone acetonide (20 mg) injection and home exercise program [40]. 
5. Continuous passive motion plus electrotherapy vs. active exercises plus electrotherapy 
[36]. 
6. 500 mg Naproxen (NSAID) and home exercise program vs. 40 mg triamcinolone and 
home exercise program [39]. 
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7. Oral medication and exercises (control) vs. Super laser plus control vs. Super laser and 
thermotherapy plus control [34]. 
8. Manipulation under anesthesia (MUA), corticosteroid plus exercises for patients with 
diabetes vs. MUA plus exercises for patients without diabetes [35]. 
 
2.4.4 Outcome measures 
 
Outcomes reported in studies were classified as: patient-reported shoulder pain (VAS) [34,36,39–
41], shoulder range of motion (goniometer) [34,36–41], and measures of shoulder function and 
disability (SPADI [36,38], CSS [35,36], ASES [40,41] and SST[40]).  
 
2.4.5 Effects of interventions 
 
Effects of Mulligan mobilization, pendular exercise and home exercise program vs. Maitland 
mobilization, pendular exercise and home exercise program:  
One trial (n = 30) assessed the effectiveness of Mulligan vs. Maitland techniques (both 
including pendular exercise and home exercise program), on shoulder range of motions and 
shoulder function and disability (SPADI), at six weeks follow up [38]. Mulligan techniques 
including pendular exercise and home exercise program demonstrated large effects in terms of 
improving shoulder range of motion, when compared to Maitland techniques with pendular 
exercise and home exercise program, at six weeks follow up [38]. SRM of 1.30, 1.08 and 1.0 
were calculated and reported for flexion, abduction and external rotation range of motions 
respectively (high risk of bias; GRADE: very low quality). Similarly, Mulligan techniques 
(plus pendular exercise and home exercise program), displayed large effects (SRM = 2.0) in 
terms of improving shoulder function and disability, when compared to Maitland techniques 
(plus pendular exercise and home exercise program), at six weeks follow up (high risk of bias; 
GRADE: very low quality) (Table 2) [38]. 
 
Effects of low-level laser therapy plus stretching exercises vs. reflexology (thumb walk) plus 
stretching exercises: 
One trial (n = 44) assessed the effectiveness of low-level laser therapy vs. reflexology (both 
including stretching exercises), on shoulder range of motion at eight weeks follow up [37]. We 
calculated and reported the between-group mean differences because SRM calculation was not 
possible due to lack of SD reporting. Low-level laser therapy plus stretching exercises 
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demonstrated between-group improvements of 14.5° (shoulder flexion), 14.0° (shoulder 
abduction) and 13.0° (shoulder external rotation), when compared to reflexology (plus 
stretching exercises), at eight weeks follow up ( high risk of bias; GRADE: very low quality) 
[37].  
 
Effects of intra-articular corticosteroids, NSAIDs plus home exercise program vs. NSAIDs plus 
home exercise program:  
One trial (n = 45) assessed the effectiveness of intra-articular corticosteroid plus NSAIDs and 
a home exercise program vs. NSAIDs plus a home exercise program on shoulder pain and 
range of motion at 24 weeks follow up [41]. Intra-articular corticosteroid plus NSAIDs and a 
home exercise program demonstrated between-group improvements of 0.4 points on VAS (0 
– 10), when compared to NSAIDs plus a home exercise program, at 24 weeks follow up 
(GRADE: very low quality) [41]. Intra-articular corticosteroid plus NSAIDs and a home 
exercise program displayed significant between-group improvements of 8.0° (shoulder forward 
elevation) and 2.0° (shoulder external rotation), when compared to NSAIDs and a home 
exercise program group, at 24 weeks follow up (high risk of bias; GRADE: very low quality) 
[41]. Intra-articular corticosteroid plus NSAIDs and a home exercise program displayed 
between-group improvements of 4.0 points on ASES, when compared to NSAIDS and a home 
exercise program group, at 24 weeks follow up (high risk of bias; GRADE: very low quality) 
[41].  
 
Effects of continuous passive motion plus electrotherapy vs. active exercises plus 
electrotherapy: 
One trial (n = 41) assessed the effectiveness of continuous passive motion vs. active exercises 
(both including electrotherapy), on shoulder pain, range of motion and shoulder function and 
disability (SPADI and CSS), at four weeks follow up [36]. Continuous passive motion plus 
electrotherapy demonstrated large effects (SRM = 1.0) in terms of reducing shoulder pain 
levels (pain in motion), when compared to active exercises plus electrotherapy, at four weeks 
follow up (high risk of bias; GRADE: very low quality) [36]. Continuous passive motion plus 
electrotherapy demonstrated moderate to large effects in terms of improving shoulder range of 
motion, when compared to active exercises plus electrotherapy, at four weeks follow up (high 
risk of bias; GRADE: very low quality) [36]. SRM of 2.0, 1.2 and 0.8 were calculated and 
reported for flexion, abduction and external rotation range of motion respectively. Continuous 
passive motion plus electrotherapy demonstrated large effects in terms of improving shoulder 
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function and disability, when compared to active exercises plus electrotherapy, at four weeks 
follow up (high risk of bias; GRADE: very low quality) [36]. SRM of 1.3 (SPADI – pain), 0.9 
(SPADI – disability) and 1.1 (CSS) were calculated and reported (Table 2) [36]. 
 
Effects of 500 mg Naproxen (NSAIDs) and a home exercise program vs. 40 mg triamcinolone 
and a home exercise program: 
One trial (n = 57) assessed the effectiveness of 500 mg Naproxen vs. 40 mg triamcinolone 
(both including a home exercise program), on shoulder range of motion and pain levels (at 
rest), at 24 weeks follow up [39]. Triamcinolone plus a home exercise program demonstrated 
trivial to moderate effects in terms of improving shoulder range of motion, when compared to 
Naproxen plus a home exercise program, at 24 weeks follow up (high risk of bias; GRADE: 
very low quality) [39]. SRM of 0.2 and 0.5 were calculated and reported for flexion and 
abduction range of motions respectively. Triamcinolone plus a home exercise program 
displayed trivial effects (SRM = 0.1) in terms of reducing shoulder pain levels, when compared 
to Naproxen plus a home exercise program at 24 weeks follow up (high risk of bias; GRADE: 
very low quality) (Table 2) [39]. 
 
Effects of oral medication and exercises (control) vs. laser therapy plus control vs. laser 
therapy, thermotherapy plus control: 
One trial (n = 84) assessed the effectiveness of control vs. laser therapy plus control vs. laser 
therapy and thermotherapy plus control, on shoulder pain levels, at 20 days follow up [34]. Laser 
therapy and thermotherapy plus control, demonstrated between-group improvements of 5.0 and 
0.9 points on VAS (0 – 10), when compared to the control group, and laser therapy plus control 
group at 20 days follow up, respectively (high risk of bias; GRADE: very low quality) [34]. 
Laser therapy plus control displayed between-group improvements of 4.1 points on VAS (0 – 
10), when compared to the control group alone at 20 days follow up (high risk of bias; GRADE: 
very low quality) [34]. 
 
Effects of triamcinolone acetonide (40 mg) injection and home exercise program vs. 
triamcinolone acetonide (20 mg) injection & home exercise program: 
One trial (n = 147) assessed the effectiveness of triamcinolone acetonide (40 mg) injection vs 
triamcinolone acetonide (20 mg) injection (both including a home exercise program), on 
shoulder range of motion, pain, function and disability levels at 12 months follow up [40]. In 
this trial, a subgroup analysis of patients with diabetes was performed but only the analysis of 
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blood parameters was provided. Therefore, we were unable to calculate and report effect sizes 
or between-group improvements (mean differences) of ASES and shoulder ROM (high risk of 
bias; GRADE: very low quality) [40]. 
 
Effects of MUA, corticosteroid and exercises vs. MUA and exercises: 
One trial (n = 26, a mix of patients with and without diabetes) assessed the effectiveness of 
MUA plus corticosteroid vs. MUA (both including shoulder exercises), on shoulder function 
at six months follow up [35]. The primary group analysis revealed a non-significant difference 
between patients who received MUA plus corticosteroids and who received only MUA 
regardless of diabetes status. The authors provided another subgroup analysis of patients with 
(n=12) and without diabetes (n=14). MUA for patients without diabetes demonstrated between-
group improvements of 5.6 points on CSS, when compared to MUA for patients with diabetes  
(high risk of bias; GRADE: very low quality) [35]. 
 
2.5 Discussion  
 
This review identified very low quality RCTs (all at high risk of bias) that demonstrated 
benefits of a variety of non-surgical treatments in managing shoulder pain, ROM and function 
in patients with diabetes who have AC. Therefore, we have very little confidence in the effect 
estimates of these individual RCTs, or which treatments might be more beneficial.  
In this systematic review, joint mobilization plus exercises [38], continuous passive motion with 
electrotherapy [36] and low-level laser therapy [37] demonstrated larger effects (better outcomes) 
on pain, ROM and function than other physiotherapeutic interventions. In addition, 
corticosteroids plus exercise were found to reduce pain, improve shoulder function and ROM 
when compared to NSAIDs plus exercise [39,41]. Lastly, shoulder function was improved with 
MUA in patients with diabetes, however, this improvement was less pronounced when 
compared to patients without diabetes [35].  
Previous systematic reviews that investigated the effectiveness of different interventions for 
managing AC have reported conflicting conclusions. A meta-analysis of three RCTs with 
severe heterogeneity revealed a short-term effect of corticosteroids (effect estimate= 0.5-0.8) 
over joint mobilization plus exercises (effect estimate = 0.1-0.7) on pain, ROM, and function 
[13]. Similarly, corticosteroid injection with poor evidence was found to provide small short-
term benefits on pain when compared to joint mobilization [18]. Another systematic review, that 
did not include a formal meta-analysis or effect size calculations, found that joint mobilization 
 40 
plus exercises and laser therapy reduced pain and improved function [16]. Two systematic 
reviews with high risk RCTs recommended the use of laser therapy and corticosteroids to 
reduce pain and the use of joint mobilization to improve shoulder ROM and function [14,17] 
which concur with the findings of the current review. Lastly, MUA did not show additional 
benefits over the use of other non-surgical or surgical interventions [15,17].  
The assessment of methodological quality of individual studies varied in these systematic 
reviews and there was no definitive consensus of the best treatment option for treating AC. In 
addition, some systematic review authors have recommended a separate analysis of patients 
with and without diabetes to consider the effect of different etiologies on the treatment effects 
[15,17].  
In comparison to the current systematic review, the large effects of some physiotherapeutic 
interventions (mobilization plus exercises and continuous passive motion) over the 
corticosteroids may be due to the long-lasting symptoms in patients with diabetes that 
permitted a longer follow-up period [12]. However, the overall evidence in this systematic 
review is of low quality and limits our ability to make recommendations on the best 
intervention for managing AC in patients with diabetes.  
Clinicians should be aware that the pathophysiology and natural history may not be consistent 
with current evidence, and that much is yet unknown.  Physicians should ensure that therapists 
are aware of the patient's diabetic status since this may affect recovery or response to treatment.  
Physiotherapists should be aware of emerging evidence on AC since the potential for changes 
in best practice is high given the low quality of current evidence.   
 
2.5.1 Study limitations 
 
This systematic review does have a number of limitations. There is very limited literature on 
the effectiveness of physiotherapeutic interventions, corticosteroids injection, and other non-
surgical interventions for the treatment of AC in patients with diabetes. While there were few 
RCTs that addressed the effect of physiotherapeutic interventions (joint mobilization, laser 
therapy, continuous passive motion, electrotherapy, reflexology, therapeutic exercises), no 
identical physiotherapeutic interventions or exercise programs were utilized in any of these 
RCTs. Similar to the physiotherapeutic intervention’s trials, RCTs that assessed corticosteroid 
injections did not follow an identical protocol that would permit meaningful comparisons. We 
found only one RCT that addressed the effect of MUA for treating AC in patients with diabetes. 
This was the result of only including studies that assessed outcomes in patients with diabetes.  
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Although we included only RCTs, the interpretation of the results is hampered by many factors 
which are related to the internal validity of these studies. All the RCTs were rated at high risk 
of bias due to the flaws in the design, conduct, analyses and reporting of the results. In regard 
to precision, some RCTs included relatively small number of patients with short follow-up 
periods. Finally, the limited number of RCTs and variability in the interventions used precluded 
meta-analyses. Future large-scale well designed RCTs involving patients with diabetes who 
have AC are required to provide an accurate estimate of treatment effects.  
 
2.6 Conclusion  
 
Very low-quality evidence indicated that a combination of physiotherapeutic interventions 
(exercises, modalities, mobilization), NSAIDs and/or corticosteroid injections, can have trivial 
to large effects in terms of improving shoulder function/disability, range of motion and pain 
levels, in managing AC in patients with diabetes. Future high quality RCTs are needed to 
determine the best intervention for managing AC in patients with diabetes and to improve the 
confidence and precision of estimated effects. 
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Box 1: MEDLINE search strategy 
 
#1,"Search diabetes" 
#2,"Search (adhesive capsulitis OR frozen shoulder)" 
#3,"Search (physiotherapy OR exercise OR manual therapy OR joint 
mobilization)" 
#4,"Search ((diabetes) AND ((adhesive capsulitis OR frozen shoulder))) AND 
((physiotherapy OR exercise OR manual therapy OR joint mobilization))" 
#5,"Search ((modalities OR electrotherapy OR rehabilitation OR 
corticosteroids))" 
#6,"Search ((diabetes) AND ((adhesive capsulitis OR frozen shoulder))) AND 
(((modalities OR electrotherapy OR rehabilitation OR corticosteroids)))" 
#7,"Search ((manipulation under anesthesia OR arthroscopy OR 
hydrodilatation OR suprascapular nerve block))" 
#8,"Search ((diabetes) AND ((adhesive capsulitis OR frozen shoulder))) AND 
((manipulation under anesthesia OR arthroscopy OR hydro dilatation OR 
suprascapular nerve block))" 
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Table 1: A summary of the included RCTs 
 
Author, year Patients 
characteristics 
DOS 
(months) & 
DOD (years) 
Intervention  Outcome measures Follow-up 
periods 
Research findings 
from baseline to last session (MeanSD, p-
value) 
Kim et al. 
2017 
n = 147 
- Group 1: 40 mg 
triamcinolone 
injection (n= 76, 
23M+53F, age = 
57.4 (45-76), n of 
diabetes = 13) 
- Group 2: 20 mg 
triamcinolone 
injection (n= 71, 
18M+53F, age = 
56.34 (47-78), n of 
diabetes = 14) 
 
DOS: at least 2 
months 
DOD: N/A 
 
- Group 1: 40 mg 
triamcinolone acetonide 
injection under sonography 
guide 
- Group 2: 20 mg 
triamcinolone acetonide 
injection under sonography 
guide 
- Both groups started HEP after 
injection (pendulum & self-
stretching passive ROM 
exercise in every plane for 4 
weeks, pulley exercise, 
isometric and strengthening 
exercises with dumbbells 
started 8 weeks after injection). 
- Pain at rest: VAS scale 
(0-10) 
- ROM: flexion, ER 
using goniometer 
(degrees) & IR; ability 
to reach scapula with tip 
of the thumb (0-4 
points) 
- ASES score 
- SST  
- Blood glucose, 
fructosamine, and 
HbA1c 
 
Baseline, 3ed, 6th, 
12th weeks, 6 and 
12 months after 
injection, and 
again at the final 
follow-up 
The subgroup analysis of patients with diabetes 
was not summarized for the clinical scores. 
Authors provided data for blood glucose, 
fructosamine, and HbA1c levels. Authors 
reported a significant higher blood glucose 
level of patients with diabetes at 6 weeks after 
injection in group 1 compared with patients 
with diabetes in group 2 (p = 0.01) 
 
Ekim et al. 
2016 
n = 41 
- Group 1: CPM 
(n= 20, 7M+13F, 
age = 60.58.1) 
- Group 2: CPT 
(n= 21, 8M+13F, 
age = 60.46.7) 
 
DOS:  
- Group 1: 10.5 
- Group 2: 8.0 
DOD:  
- Group 1: 
10.64.8 
- Group 2: 
7.955.4 
Group 1: CPM 1 h/day for 4 
weeks (5 days/week) 
Group 2: CPT (active 
stretching, ROM & pendulum 
exercises 1 h/day for 4 weeks 
(5 days /week) 
Both groups received 20 min 
hot-pack, 5 min US, 20 min 
TENS, and HEP for 8 weeks 
(pendulum and passive ROM 
exercises) 
- Pain: VAS scale (0-
10) at rest, night, & 
during motion 
- Active & passive 
ROM: flexion, 
abduction, ER using 
goniometer (degrees) 
and IR; ability to reach 
scapula with tip of 
thumb (degrees) 
- CSS & SPADI: 
shoulder pain and 
function 
 
 
Baseline, 4th, 12th 
weeks 
Group 1:  
- Pain at rest 5.01.6 - 2.61.1 (0.001) 
- Pain on motion 7.41.5 - 4.01.1 (0.001) 
- Pain at night 8.151.09 - 4.350.88 (0.001) 
- Active abduction 86.514.0 - 123.815.4 
(0.001) 
- Passive abduction 95.516.2 - 130.516 
(0.001) 
- Active flexion 103.915.8 - 14311.3 (0.001) 
- Passive flexion 11215.9 - 150.511 (0.001) 
- Active ER 31.519.6 - 58.015.0 (0.001) 
- Passive ER 38.321.7 - 65.315.1 (0.001) 
- Active IR 41.321.0 - 70.313.2 (0.001) 
- Passive IR 46.020.9 - 77.010.9 (0.001) 
- SPADI pain 79.18.2 - 50.09.1 (0.001) 
- SPADI disability 67.59.2 - 42.88.3 (0.001) 
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- CSS 32.18.5 - 50.85.6 (0.001) 
Group 2: 
- Pain at rest 5.91.4 - 3.71.5 (0.001) 
- Pain on motion 7.81.3 - 5.21.5 (0.001) 
- Pain at night 8.620.86 - 5.861.74 (0.001) 
- Active abduction 90.711.1 - 111.915.4 
(0.001) 
- Passive abduction 97.912.5 - 119.517.4 
(0.001) 
- Active flexion 113.810.6 - 131.412.7 
(0.001) 
- Passive flexion 118.310.2 - 13912.4 
(0.001) 
- Active ER 42.1414.7 - 55.517.6 (0.001) 
- Passive ER 48.815.5 - 61.717.6 (0.001) 
- Active IR 46.212.0 - 62.617.9 (0.001) 
- Passive IR 52.111.3 - 68.117.1 (0.001) 
- SPADI pain 81.06.6 - 63.29.7 (0.001) 
- SPADI disability 72.97.4 - 56.110.8 
(0.001) 
- CSS 32.87.5 - 43.48.3 (0.001) 
Youssef et al. 
2015 
n = 30 
- Group 1: 
Mulligan (n= 15, 
age = 54.85.85) 
- Group 2: 
Maitland (n= 15, 
age = 53.45.23) 
 
DOS: at least 3 
months 
DOD: at least 
5 years 
- Group 1: Mulligan joint 
mobilization techniques, 3 
times / week for 6 weeks. 
Passive accessory glide 
combined with active arm 
motion in three sets of 10 
repetitions in each direction 
- Group 2: Maitland joint 
mobilization techniques, 3 
times / week for 6 weeks. 
Oscillatory end-range 
mobilization grade III or IV 
- Both groups received 
pendulum exercises in all 
directions for 5 min and HEP 
(pendulum exercise and 
ADLs) 
- SPADI 
- Active ROM: flexion, 
abduction, IR, and ER 
using a digital level 
inclinometer  
Baseline and 6 
weeks 
Group 1:  
- SPADI: 85.154.24 - 16.365.68 (p < 0.01) 
- Flexion: 52.7410.51 - 144.2822.23 (p < 
0.01) 
- Abduction: 39.4615.55 - 133.8022.27 (p < 
0.01) 
- ER: 24.5711.16 - 83.866.38 (p < 0.01) 
- IR: 45.66.01 - 69.466.61 (p < 0.01) 
Group 2:  
- SPADI: 82.37.21 - 32.7622.02 (p < 0.01) 
- Flexion: 52.7812.73 - 119.3630.27 (p < 
0.01) 
- Abduction: 40.5719.69 - 111.9626.91 (p < 
0.01) 
- ER: 25.0114.14 - 73.314.72 (p < 0.01) 
- IR: 45.735.44 - 67.567.21 (p < 0.01) 
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- Authors also reported more improvement in 
Mulligan group in SPADI and flexion, 
abduction and ER ROM as compared to 
Maitland group 
 
Soliman et al. 
2014 
n = 44 
- Group 1: Low-
level laser therapy 
(LLLT) (n= 20, 
6M+14F, age = 
59.553.03) 
- Group 2: 
Reflexology (n= 
20, 16M+4F, age 
= 57.77.98) 
 
DOS: 2-7 
months 
DOD > 4 years 
- Group 1: LLLT for 15 min, 3 
times / week for 8 weeks using 
laser applicator 
- Group 2: reflexology in the 
form of thumb walk for 15 min, 
3 times / week for 8 weeks in 
upward, downward and 
diagonal directions over the 
shoulder area on the bottom of 
the foot under the little toe 
- Both groups received 
exercise program for 15 min 
(ER-passive stretch, forward 
flexion-supine position, 
crossover arm stretch, pendular 
exercise, hand behind back 
exercise). Each exercise was 
repeated 10 times 
- Shoulder ROM: 
forward flexion, 
abduction, IR, and ER 
using goniometer 
(degrees)  
Baseline, 4th, 8th 
week 
No ROM values were summarized in a table 
except for the baseline data.  
Authors reported the following:  
- Significant increase in abduction (p < 0.001) 
in both groups at 4 and 8 weeks as compared to 
baseline.  
- Significant increase in ER (p < 0.001) at the 4 
and 8 weeks in LLLT group compared to 
baseline 
- Reflexology was less effective at 4 and 8 
weeks compared to LLLT group 
- Significant increase in IR (p < 0.001) at 4 and 
8 weeks in LLLT group 
- Significant increase in IR (p <0.05) at 8 weeks 
in reflexology group 
- Significant increase in flexion (p <0.001) at 4 
and 8 weeks in LLLT group 
- Significant increase in IR (p <0.05) at 4 and 8 
weeks in reflexology group but it was less than 
LLLT group 
Dehghan et 
al. 2013 
n = 57 
- Group 1: 
Naproxen 
(NSAID) (n= 28, 
11M+17F, age = 
52.86.7) 
- Group 2: CS 
injection (n= 29, 
8M+21F, age = 
55.37.7) 
 
DOS < 6 
months 
DOD:  
- Group 1: 
9.37.0 
- Group 2: 
9.55.8 
- Group 1: 500 mg Naproxen 
(NSAID) twice daily  
- Group 2: single injection of 
40 mg triamcinolone under 
sonography guide 
- Oral NSAID was 
administered for all patients 
who started HEP after 1 week 
(shoulder flexion, abduction, 
IR, 3 sessions/day, 15 
reps/session). 
- Pain at rest: VAS scale 
(0-10) 
- ROM: flexion, 
abduction, ER using 
goniometer (degrees) & 
IR; ability to reach 
scapula with hand (plus 
0-4) 
 
 
Baseline, 2nd, 6th, 
12th, and 24th 
weeks 
Group1:  
- Pain: 5.642.43 - 1.991.98 (0.001) 
- Flexion: 107.615.7 - 167.622.0 (0.001) 
- Abduction: 99.222.6 - 170.022.9 (0.001) 
- ER: 28.29.5 - 45.79.8 (0.001) 
- IR: 2.60.87 - 0.320.54 (0.001) 
Group2:  
- Pain at rest: 6.182.17 - 2.242.06 (0.001) 
- Flexion: 103.722.3 - 167.424.2 (0.001) 
- Abduction: 90.621.3 - 172.921.6 (0.001) 
- ER: 30.811.7 - 47.411.4 (0.001) 
- IR: 2.51.01 - 0.240.43 (0.001) 
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Roh et al. 
2012 
n = 45 
- Group 1: CS 
injection (n= 23, 
16M+7F, age = 
54.410.9) 
- Group 2: 
NSAIDs (n= 22, 
14M+8F, age = 
55.311.2) 
 
DOS:  
- Group 1: 
6.24.3 
- Group 2: 
6.54.0 
 
DOD: N/A 
- Group 1: intra-articular CS 
composed of 40 mg 
triamcinolone acetonide under 
sonography guide. Patients 
were also offered oral 
NSAIDs.  
- Group 2: NSAIDs 
- Both groups received HEP 
initiated one day after injection 
(4-quadrant stretching program 
in flexion, ER, IR, and cross-
body adduction for 3 
times/day).  
- Pain at rest: VAS scale 
(0-10) 
- ROM: passive flexion, 
ER at 0 abduction using 
goniometer (degrees) & 
IR; ability to reach 
scapula with tip of the 
thumb (0-10 points) 
- ASES score 
 
 
Baseline, 4th, 
12th, and 24th 
week  
No values were presented for pain, ROM, and 
ASES.  
Authors reported the following: - Significant 
lower VAS scores in group 1 at 4-week follow-
up (p = 0.02) 
- Flexion (p = 0.03) and IR (p = 0.045) ROM 
were higher in group 1 at 12-week follow-up 
than group 2  
- Significant difference in ASES between 
groups at 12-week follow-up 
  
Liang et al. 
2012 
n = 84 
- Group 1: control 
(n = 28, 
12M+16F, age = 
54.363.87) 
- Group 2: Super 
laser (n = 28, 
10M+18F, age = 
53.643.29) 
- Group 3: Super 
laser + 
thermotherapy (n 
= 28, 13M+15F, 
age = 53.684.02) 
DOS:  
- Group 1: 
6.642.12 
- Group 2: 
6.642.18 
- Group 3: 
6.572.02 
 
DOD: N/A 
- Group 1: oral medication and 
shoulder exercises 30 to 40 
times per day for 20 days.  
- Group 2: super laser using 
probe (intermittent followed 
by continuous irradiation for 7 
min on each trigger point with 
output power of 80 to 100%, 
one time per day for 20 days) + 
group 1 treatment. 
Group 3: including the 
treatment of group 1 and 2 in 
addition to thermotherapy 
(using fumigation tank, 
temperature between 38 to 
45℃, 30 min per day for 20 
days). Traditional Chinese 
medicine was added to the tank 
(medicine names and amounts 
are listed in the original 
article).  
 
 
- The degree of 
shoulder pain (VAS) 
and shoulder movement 
(integral score) as 
follow: 
* Cure:  
VAS = 0 
Integral score = 0 
* Effective:  
0 <VAS≤ 2 
Integral score: ≤ 4 
points 
* General: 
2 <VAS≤ 5 
Integral score: from 5 to 
7 points 
* Invalid:  
VAS> 6  
Integral score is 8 to 12 
points 
Baseline, and 20 
days after 
treatment  
- Group 1: (n = 28,%) 
Cure 0 (0) 
Effective 1 (3.57) 
General 5 (17.86) 
Invalid 22 (78.57) 
- Group 2: (n = 28,%) 
Cure 7 (25) 
Effective 11 (39.28) 
General 10 (35.72) 
Invalid 0 (0) 
- Group 3: (n = 28,%) 
Cure 12 (42.85) 
Effective 10 (35.71) 
General 6 (21.44) 
Invalid 0 (0) 
The authors reported that the greatest 
improvement was noted in group 3 as 
compared to the other two groups. Group 2 had 
also better outcomes compared to group 1 
(control).  
Guity et al. 
2007 
n = 26, 12 patients 
with diabetes 
5M+21F 
DOS: N/A 
 
DOD: N/A 
Group 1: MUA + CS. 
Intravenous CS was provided 
prior to manipulation which 
Pain and ROM: CSS 
questionnaire (0-100)  
Baseline, two and 
six weeks, then 
Authors reported statistically significant 
improvement in both groups overtime with a 
non-statistically significant difference between 
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Age = 55.75.1 
- Group 1: MUA + 
CS injection (n = 
13) 
- Group 2: MUA 
(n = 13) 
Another subgroup 
analysis for 
patients with 
diabetes (n=12) 
and patients 
without diabetes 
(n= 14) were 
provided when the 
effect of CS 
between the 
primary groups 
was non-
significant 
 
was done from supine position 
while the affected shoulder 
was flexed, and then moved 
into 90 degrees of abduction 
and then rotated outward.  
All patients received shoulder 
exercises. 
Group 2: MUA and shoulder 
exercises.  
three and six 
months  
patients who received MUA +CS and only 
MUA:  
Group 1:  
Before MUA: 29.47.4 
After MUA: 86.98.5 
Group 2:  
Before MUA: 284.2 
After MUA: 82.75.1 
From the sub-analysis of patients with diabetes:  
Patients with diabetes:  
Before MUA: 25.93.2 
After MUA: 794.9 
Patients without diabetes:  
Before MUA: 31.16.8 
After MUA: 89.84.6       
Authors reported a statistically significant 
difference between patients with and without 
diabetes (p = 0.01) 
 
RCT: randomized clinical trial, NSAID: non-steroidal anti-inflammatory drug, CS: corticosteroids, M: male, F: female, DOS: duration of symptoms, DOD: duration of diabetes, HEP: home exercise program, IR: internal 
rotation, ER: external rotation, VAS: visual analogue score, ROM: range of motion, CPM: continuous passive motion, CPT: conventional physiotherapy treatment, CSS: constant shoulder score, SPADI: shoulder pain 
and disability index, US: ultrasound, TENS: transcutaneous electrical nerve stimulation, ASES: American shoulder and elbow surgeons, SST: simple shoulder test, MUA: manipulation under anesthesia.  
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Figure 1: Flow diagram showing study selection process 
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Figure 2: Risk of bias summary- review authors’ judgements about each risk of bias item for 
each included study 
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Table 2: A summary of the original outcome measures and the Standardized Response Mean 
SRM: Standardized Response Mean, SD: standard deviation, ER: external rotation, SPADI: shoulder pain and disability index, CSS: 
constant shoulder score.  
 
  
Study Outcome measure mean and SD SRM 
 
 
Ekim et al. 2016 
- Group 1: pain in motion 7.41.5 - 4.01.1  
- Group 2: pain in motion 7.81.3 - 5.21.5 
 
- Group 1: active flexion 103.915.8 - 14311.3 
- Group 2: active flexion 113.810.6 - 131.412.7 
 
- Group 1: active abduction 86.514.0 - 123.815.4 
- Group 2: active abduction 90.711.1 - 111.915.4 
 
- Group 1: active ER 31.519.6 - 58.015.0 
- Group 2: active ER 42.1414.7 - 55.517.6 
 
- Group 1: SPADI pain 79.18.2 - 50.09.1  
- Group 2: SPADI pain 81.06.6 - 63.29.7 
 
- Group 1: SPADI disability 67.59.2 - 42.88.3 
- Group 2: SPADI disability 72.97.4 - 56.110.8 
 
- Group 1: CSS 32.18.5 - 50.85.6  
- Group 2: CSS 32.87.5 - 43.48.3 
 
1.0 
 
 
2.0 
 
 
1.2 
 
 
0.8 
 
 
1.3 
 
 
 
0.9 
 
 
1.1 
 
Youssef et al. 2015 
 
- Group 1: SPADI 85.154.24 - 16.365.68  
- Group 2: SPADI 82.37.21 - 32.7622.02 
 
- Group 1: flexion: 52.7410.51 - 144.2822.23 
- Group 2: flexion: 52.7812.73 - 119.3630.27 
 
- Group 1: abduction: 39.4615.55 - 133.8022.27 
- Group 2: abduction: 40.5719.69 - 111.9626.91 
 
- Group 1: ER: 24.5711.16 - 83.866.38  
- Group 2: ER: 25.0114.14 - 73.314.72  
 
2.0 
 
 
1.30 
 
 
1.08 
 
 
1.0 
 
Dehghan et al. 2013 
- Group 1: pain: 5.642.43 - 1.991.98 
- Group 2: pain 6.182.17 - 2.242.06 
 
- Group 1: flexion: 107.615.7 - 167.622.0  
- Group 2: flexion: 103.722.3 - 167.424.2 
 
- Group 1: abduction: 99.222.6 - 170.022.9  
- Group 2: abduction: 90.621.3 - 172.921.6 
 
0.1 
 
 
0.2 
 
 
0.5 
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CHAPTER 3: 
 
PHYSIOTHERAPY EXERCISE PROGRAM FOR MANAGING 
ADHESIVE CAPSULITIS IN PATIENTS WITH AND 
WITHOUT DIABETES: A PILOT RANDOMIZED TRIAL 
 
 
 
The manuscript is submitted to the Archives of Orthopaedics  
 
 
Alsubheen SA, MacDermid JC, Overend TJ, Faber KJ, Furtado R. Effect of physiotherapy 
program on shoulder performance for managing adhesive capsulitis in patients with diabetes: 
A pilot randomized trial. Submitted to the Archives of Orthopaedics Journal.  
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Abstract 
 
Study design: Prospective randomized pilot trial 
Background: Adhesive capsulitis (AC) occurs five times more often in people with diabetes. 
Exercises are usually recommended to manage AC. However, the recovery is slow and often 
incomplete, especially for patients with diabetes. Aerobic exercises improve hyperglycemia 
and insulin sensitivity. Currently, no research has formally assessed the benefits of 
incorporating an aerobic walking training program into the treatment plan of AC in patients 
with diabetes.  
Purpose: This pilot trial compared the effect of a regular physiotherapy (PT) program (PT) to 
a regular PT program combined with a progressive walking program (PT+) in patients with 
and without diabetes who have AC. 
Methods: Eight patients with (n = 3) and without (n = 5) diabetes (five men and three women, 
with mean age of 57 years) were included. Patients were randomly allocated either to PT or 
PT+ groups. The primary outcome of shoulder function was measured using the Functional 
Impairment Test-Hand and Neck/Shoulder/Arm (FIT-HaNSA) test. Secondary outcomes 
included shoulder pain and function; shoulder range of motion in flexion, abduction, and 
external rotation; muscle strength of shoulder flexors and abductors; and physical activity level. 
The primary outcome was evaluated at baseline and after six weeks. Secondary outcomes were 
evaluated at baseline, and after three, six and 12 weeks from enrollment.  
Setting: Single centre study at a tertiary-care hospital. 
Results: A total of 13 patients were contacted with study details, only eight patients agreed to 
participate, with a 62% recruitment rate. Adherence with research centre visits was 97%. 
Patients in both groups showed improvement in all outcome measures. The FIT-HaNSA scores 
had a mean improvement of  3817 in the PT group and  633  in the PT+ group from baseline 
to six weeks follow-up. Future studies, with 80% power (α= 0.05, β= 0.20) to detect a 20% 
between-group difference, would require a sample size of 89 participants per group.  
Conclusion: This pilot trial established that conducting a large-scale study to assess the effect 
of physiotherapy program for managing AC is feasible. The current findings suggest that 
physiotherapy exercises may be effective in reducing pain and improving shoulder function 
and ROM in patients with and without diabetes who have AC. Researchers should be aware of 
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the recruitment challenges and should work on minimizing performance and detection bias by 
blinding study personnel and outcome assessors. 
 
Trial registration: ClinicalTrials.gov, ID number: NCT03462420. Registered 30 January 
2018, https://register.clinicaltrials.gov/prs/app/action/LoginUser?ts=2&cx=-jg9qo3 
 
Keywords: Adhesive capsulitis, Diabetes, Physiotherapy, Pilot trial 
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3.1 Background 
 
Adhesive capsulitis (AC), also known as ‘frozen shoulder’, is characterized by the 
development of dense adhesions and capsular thickening leading to a progressive and painful 
restriction of shoulder range of motion (ROM) and functional disability [1]. The onset is 
gradual, usually occurs between the ages of 40 and 60 years [2] and is more common in females 
and patients with diabetes [3].   
Adhesive capsulitis has been described as a self-limiting condition that progresses through  
pain, frozen and thawing phases. However, Wong et al. examined the quality of the evidence 
that describes the theory of AC phases and reported a lack of evidence to support these 
theoretical phases of AC [4].  
Based on Codman’s criteria [5], the condition can be classified as primary or secondary AC. 
Primary or idiopathic AC has no clear underlying cause [5]. However, secondary AC might 
develop following soft tissue injury, joint arthritis, or secondary to known systemic disease 
such as diabetes [6]. The association between diabetes and AC was first reported by Bridgman 
(1972) who found that 10.8% of patients with diabetes had AC as compared to 2.3% for patients 
without diabetes [7]. Subsequent studies have supported this association and reported a 
prevalence of AC in 10-76%  type 1 and 7-30% type 2 diabetes as compared to 0-10% in the 
general population [1,8–11]. Adhesive capsulitis was also reported to be associated with age in 
both types of diabetes [8] and with the duration in type 1 diabetes [9,10,12]. 
The pathophysiology that predisposes patients with diabetes for the development of AC is not 
well-understood. Proposed mechanisms that may lead to AC include increased glycosylation 
of collagen fibers of the joint capsule and diabetic microangiopathy induced fibrosis [1,13,14].  
The usual approach for managing AC includes steroid injections, joint mobilization techniques 
and the implementation of shoulder exercises to restore function. Several systematic reviews 
reported that active exercises and joint mobilization can reduce pain, restore shoulder ROM 
and function in both short- and long-term follow up [15–18], while moderate-quality evidence 
showed a short-term beneficial effect of steroid injection in reducing pain during the early stage 
of AC [15–17,19]. Only one recent systematic review has assessed the effectiveness of non-
surgical intervention for managing AC in patients with diabetes and reported that low quality 
evidence suggests large effects of joint mobilization plus exercises on AC in patients with 
diabetes with a weaker support for the use of steroid injection and manipulation under 
anesthesia [20].  
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Although some of the non-surgical interventions have been shown to be effective in managing 
AC, recovery is slow and often incomplete, especially for people with diabetes [21]. Patients 
with diabetes often develop long-lasting shoulder stiffness, higher shoulder pain, functional 
disability and reduced ROM than patients without diabetes [9,10,22,23]. Furthermore, greater 
shoulder pain and disability were associated with poor glycemic control and diabetic 
complications [24]. 
Aerobic exercises can improve hyperglycemia and insulin sensitivity in skeletal muscle, and 
induce a favorable effect on blood vessels that can reduce diabetes related complications such 
as hypertension, hyperlipidemia, and obesity [25]. These effects may have a greater impact on 
the AC pathophysiology. However, none of the previous research has formally assessed the 
benefits of incorporating an aerobic training program into the treatment plan of AC in patients 
with diabetes. At present, there is no optimal physical therapy protocol for managing AC in 
patients with diabetes.  
The purpose of this pilot randomized trial was to compare the effect of a regular physiotherapy 
(PT) program to a regular PT combined with a progressive walking program (PT+) in patients 
with and without diabetes who have AC. This pilot trial also evaluated the feasibility of 
recruitment, randomization, retention, assessment procedures, and implementation of the novel 
intervention. Data from this pilot trial was used to calculate an accurate sample size for a full-
scale randomized clinical trial RCT. The secondary objective was to determine if diabetes 
affects response to treatment. 
 
3.2 Methods and materials  
 
 3.2.1 Study design and setting 
 
A prospective single-blinded parallel pilot RCT was conducted at a tertiary hospital. Local 
Research Ethics Board has approved the study (Project ID: 111647).  
 
3.2.2 Inclusion and exclusion criteria 
  
Inclusion criteria: 1) A confirmed diagnosis of AC. A diagnosis of AC was confirmed by the 
consultant shoulder surgeon (KF), who was blinded to treatment allocation, based on the 
following diagnostic criteria: shoulder pain for at least one month; inability to sleep on the 
affected side; and restriction of active and passive ROM in one or more planes [26]; 2) Patients 
aged 18 years or more; 3) Ability to participate in the study and follow treatment instructions.  
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Exclusion criteria: Patients with previous shoulder surgery, significant shoulder injury within 
six-months, history of shoulder dislocation or arthritis, and patients with suspected rotator cuff 
disease were excluded from this study.   
 
3.2.3 Outcome measures   
 
3.2.3.1 Primary outcome measure 
 
The primary outcome was the Functional Impairment Test - Hand and Neck/Shoulder/Arm 
(FIT-HaNSA) test. The FIT-HaNSA test measures the functional performance of the upper 
limb, while performing multi-level tasks. In the first task (waist-up), the patient lifts three one-
kg containers one at a time, with the affected arm, between a shelf at waist level and a shelf 25 
cm higher at speed of 60 beats per minute for five minutes or until patient is unable to continue. 
In the second task (eye-down), the patient returns the three containers back to the waist level 
shelf. In the third task (overhead work), using both arms, the patient repeatedly screws and 
unscrews bolts to simulate overhead work for five minutes or until the patient feels unable to 
continue. Each task was timed with a stopwatch and the rhythmic speed was controlled using 
an auditory metronome (Soundbrenner, Berlin). All tasks were performed from a standing 
position. This test has been shown to be valid and reliable [27].  
 
3.2.3.2 Secondary outcome measures 
 
Secondary outcomes included shoulder range of motion (ROM) in flexion, abduction, and 
external rotation using a standard goniometer; shoulder pain and function using Shoulder Pain 
and Disability Index (SPADI) questionnaire; muscle strength of shoulder flexors and abductors 
using a dynamometer; and physical activity level using an accelerometer (Fitbit) and the Rapid 
Assessment of Physical Activity (RAPA) questionnaire. Secondary outcome measures were 
collected by a single physiotherapist at baseline, and at three, six, and 12 weeks.  
 
Shoulder ROM 
Shoulder ROM was measured using a standard goniometer with known concurrent validity and 
reliability [Intraclass Correlation Coefficients (ICCs) > 0.94] [28]. Active flexion and abduction 
ROM were assessed by measuring the angle formed by the arm and thorax from sitting position. 
The axis of the goniometer was located at the acromion process; the movable bar was parallel 
to the humerus while keeping the stationary bar parallel to the trunk [29].  
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Active external rotation was assessed in sitting position with the arm adducted and the elbow 
at the side and flexed to 90 degrees. The axis of the goniometer was located at the olecranon 
process of the elbow and both the stationary and movable bars were parallel to the forearm [29].  
 
Shoulder pain and function  
Shoulder pain and function were assessed using SPADI questionnaire [30]. This self-report 
questionnaire consists of two subscales: pain (five items) and function (eight items). The pain 
subscale is rated on scale from zero (no pain) to 10 (worst pain ever). The patient is asked to 
circle the number that best describes their pain and/or disability. The subscale scores are 
calculated by adding the item scores for that subscale and dividing this number by the 
maximum score possible for the items that are deemed applicable by the subject. This number 
is then multiplied by 100. The two subscales are then added and the total out of 130 is then 
multiplied by 100.  Higher scores indicate greater impairment or disability [30,31].  
The SPADI has been shown to be a valid and reliable measure of shoulder pain and disability 
[32]. A SPADI score can detect change over time, accurately discriminates among patients who 
have improved or worsened [31] and has been used in patients with AC [33,34]. 
 
Muscle strength  
Isometric muscle strength was assessed for shoulder flexors and abductors using the JTech 
Power Track handheld dynamometer (JTech; JTech Medical, Salt Lake City, UT, USA), with 
known concurrent validity [35] and reliability (ICCs 0.89-0.98) [36]. Patients were seated on a 
straight back chair to stabilize the trunk. Abductor strength was measured by placing the device 
on the lateral aspect of mid-humerus and flexor strength was measured by placing the device 
on the anterior aspect of the upper arm.  
 
Assessment of physical activity level  
Physical activity level was measured objectively using an accelerometer (Fitbit Zip) and 
subjectively use a self-reported questionnaire (RAPA). Physical activity level was objectively 
measured using the Fitbit Zip (Fitbit Inc, USA). This activity tracker contains a three-
dimensional accelerometer and is designed to track steps, distance and calories burned. Fitbit 
Zip is small and discreet and can be worn in a pocket, on a belt or on a bra. Data from the Fitbit 
Zip syncs automatically to a computer or smartphone using free online application software. 
Participants were asked to wear the device during all waking hours and to sync their devices 
on a daily basis for six consecutive weeks. Step count and distance data were obtained from 
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the Fitbit Zip and summarised into an activity tracking sheet. This device has been validated 
and found to be comparable to other accelerometers [37,38]. Physical activities were subjectively 
assessed using RAPA which consists of nine self-reported questions that assess physical 
activity levels with a response option of yes or no. The first seven questions assess weekly 
aerobic activity ranging from sedentary to vigorous levels with a total score of 1-7 points, 
where 1 = rarely do any physical activity, and 7 = 20 minutes of vigorous activities 3+ 
days/week. A respondent's physical activity score is categorized into one of five levels of 
physical activity: sedentary, underactive, regular underactive (light activities), regular 
underactive, and regular active. The other two questions assess strength and flexibility training 
with a total score of three points; one point for strength training and two points for flexibility 
training. A full description of RAPA is published [39]. The RAPA questionnaire has been 
validated for use in clinical practice with older adults [39].  
 
3.2.4 Procedures 
 
Patients with and without diabetes, who have been diagnosed with AC were recruited from 
orthopedic clinics at our tertiary hospital via surgeon referrals. Eligible patients were then 
given a letter of information and were asked to sign a consent form. After signing the consent 
form, patients attended an orientation session and were provided with information about the 
study and the experimental design. Patient's weight, height, age, gender, type and treatment of 
diabetes, affected shoulder side (right or left; dominant or non-dominant), and the duration of 
AC symptoms were collected during this session. Patients were then asked to complete two 
outcome questionnaires (SPADI and RAPA) and a Katz comorbidity scale [40]. 
Next, patients underwent blinded randomization into one of the two groups: regular PT 
program or regular PT with a progressive walking program (PT+). The randomization was 
stratified by intervention (walking program) and diabetes status using a computer-generated 
random number table. Patients were allocated into groups using sequentially numbered, 
opaque, and sealed envelopes issued by the blinded assistant research.  
The initial intention of this study was to refer all patients to physical therapy facilities according 
to their preferences. However, because some patients were recently completed their PT 
treatment and some others were unable to start a formal PT treatment due to the long wait list 
at physiotherapy clinics, those patients were provided with a home exercise program from the 
research team. This program included a group of shoulder exercises that are proven to improve 
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shoulder clinical outcomes in patients with AC. A detailed exercise program is described online 
[41].  
In the PT+ group, patients were instructed to walk at their own pace for 30-45 min, five days 
per week for six consecutive weeks. They recorded their walking date/time on a diary form 
provided by the research team. Patients in the PT+ group were not restricted from walking 
more than 45 minutes a day, as long as they did not feel tired or uncomfortable. Patients in 
both groups were provided with a Fitbit Zip accelerometer to accurately estimate their physical 
activity level.  
Diabetes Canada is recommending a minimum of 150 minutes per week of at least moderate-
intensity cardiorespiratory exercise to improve cardiovascular risk [42]. Improvements in 
arterial stiffness and insulin resistance have been documented after only three weeks of aerobic 
exercise training. To maintain a long-term effect, longer durations are recommended [43].  
Walking is type of cardiorespiratory exercise training that is affordable and easy, costs nothing, 
safe and gentle enough for patients with comorbidities and can be done anytime, just about 
anywhere. However, patients with diabetes must be checked for the presence of diabetic foot 
as this may prevent the ability of patients to walk due to the potential adverse effect of 
weightbearing exercises on foot health [44].   
The primary outcome measures were evaluated by a single research team member at baseline 
and after six weeks. Secondary outcomes were evaluated at baseline, at three and six weeks, 
and again at 12 weeks after enrollment (Figure 1).  
 
3.2.5 Statistical Analysis 
 
Statistical analysis was performed using SPSS, version 21 (SPSS Inc., Chicago, IL, USA). The 
analysis of this pilot study is mainly descriptive. Estimates of means and standard deviations 
for continuous outcomes measures, and an estimate of the proportion for categorical outcome 
measures were calculated. The recruitment rate was calculated by dividing the total number of 
patients who consented to participate by the total number of patients contacted with study 
details. The attendance rate was calculated by dividing the actual number of visits by the total 
number of all patients’ visits.  
 
3.3 Results  
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Thirteen consecutive patients with AC were referred by the orthopedic surgeon (KF) between 
September 2018 and November 2019. Of the 13 patients contacted with study details, only 
eight patients, including three patients with diabetes, agreed to participate in this study,  
 a 62% recruitment rate (8/13). Adherence with scheduled research centre visits was excellent 
with a 97% attendance rate (31/32). Only one patient missed the final follow-up visit which 
included completing SPADI and RAPA questionnaires and measures of active ROM and 
muscle strength.  
This study included five male and three female patients with mean age of 57 years. Table 1 
presents the clinical characteristics of patients for both PT and PT+ groups. Six patients were 
allocated in the PT group, including three patients with diabetes, and two patients were 
allocated in the PT+ group. Patients in the PT group were overweight with a Body Mass Index 
(BMI) of 26 and reported more comorbidities (Table 1).  
Three patients (two in PT+) were enrolled in a formal physiotherapy program that included 
ROM, stretching and strengthening exercises (two patients received one session/month; one 
patient received 12 sessions: two sessions/week), and five patients were provided a home 
exercise program by the research team (the five patients completed a formal PT program before 
the beginning of this study which included PT modalities and exercises).  
 
3.3.1 Change over time in outcome measures  
 
All patients showed improvement over the six weeks follow-up time in the FIT - HaNSA 
outcome measure (from 155±89 to 180±88). This improvement was more pronounced in the 
PT group as illustrated in Table 2. Similarly, all patients had improvements in SPADI (pain, 
function, total), active ROM (flexion, abduction, external rotation), and muscle strength 
(flexors and abductors) over the 12-week follow-up period. The improvement of these outcome 
measures was more pronounced in the PT group when compared to PT+ group (Table 2).  
The physical activity level of both groups remained the same throughout the study (RAPA = 
6) (Table 2). When comparing groups, the PT+ group was more active at the six and 12-week 
follow-up times (RAPA = 7, 8, respectively) and showed higher step counts and longer 
travelled distances over the six-week use of the Fitbit activity tracker (Table 3). 
 
3.3.2 A comparison between patients with and without diabetes 
 
Table 4 and 5 present a comparison between patients with and without diabetes for all outcome 
measures. In general, patients with diabetes were younger (53±11 years) and had AC for a 
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longer period of time (29±38 years). In addition, patients with diabetes had worse baseline 
outcome measures and their improvement at six weeks was less pronounced when compared 
to patients without diabetes. However, patients with diabetes showed higher improvement at 
12-week follow-up period compared to patients without diabetes in response to a physiotherapy 
exercise program (Table 4).  
The level of physical activity for patients with diabetes was less at baseline (RAPA = 5) but 
increased over time and became higher than patients without diabetes at week 12 (RAPA = 7). 
However, patients without diabetes showed a higher step count and longer travelled distances 
as compared to patients with diabetes over the six-week use of the Fitbit activity tracker as 
presented in Table 5.  
 
3.3.3 Sample size:  
 
Sample size calculations were based on the mean FIT-HaNSA scores and the pooled Standard 
Deviation (SD) at the six-week follow-up visit. We calculated the sample size for future studies 
using the following equation [45]:  
 
 
 
 
 
 
Where,  
N = size per group; 
1-β = the power to detect a difference if one truly exists; for 80% this is 0.84 
α = the probability of making a Type I error = 0.05; 
zx= the z-score/standard normal deviate for a two-sided x; for 5% this is 1.96 
S2= Pooled standard deviation of both comparison groups = 88; 
δ = a clinically acceptable margin = 36. This was determined by calculating a 20% clinically 
important difference in the follow-up mean score.   
N = 2 x (1.96 + 0.84 / 36)2 x (88)2 = 77 per group 
Total = 2 x 77 = 154 
Considering a drop-out rate of 15%, the total sample size required is 178 (89 per group).  
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3.4 Discussion  
 
This prospective randomized pilot trial determined that conducting a large-scale study to assess 
the effect of physiotherapy program for managing AC is feasible. However, the effect of adding 
a progressive walking program to PT  exercises was not tested for patients with diabetes due 
to the stratified randomization with this small sample; all patients with diabetes (n = 3) were 
randomized to the regular PT program group.  
Participant recruitment was satisfactory and there were no dropouts. For future studies, a 
sample size of 178 (89 participants per group), to detect 20% difference between-groups is 
required. Seven patients would need to be recruited each month over 26-month period to 
successfully complete the trial in a single Centre. A multicenter approach may be more 
pragmatic and efficient. 
This study demonstrated that clinical outcomes including shoulder performance, shoulder pain 
and function, active ROM, and muscle strength improved in patients with AC over a 12-week 
follow-up period. The improvement was more pronounced in the PT group as compared to PT+ 
group; however, we consider these results unstable due to the very low sample size of PT+ 
group. However, patients in PT+ group were more physically active as indicated by RAPA and 
Fitbit results. This can be due to the nature of our study in which the research team encouraged 
patients in the PT+ group to perform regular walking activity. Provision of the Fitbit might in 
itself have acted as a motivator for improving physical activity; since this is not standard 
practice. 
Although patients with diabetes had worse outcome measures at baseline, they improved 
overtime and showed greater recovery at week 12 when compared to patients without diabetes. 
At the 12-week follow-up visit, two patients without diabetes reported severe pain and inability 
to move their arm after performing intensive housekeeping activities. This may explain the 
inferior recovery in the patient without diabetes group. However, the level of physical activity 
was lower in patients with diabetes at baseline as indicated by the Fitbit results although the 
RAPA score was higher in patients with diabetes. The sample size was too small to detect 
treatment differences and to make definitive conclusions. However, the preliminary findings 
of this study, including the excellent adherence rate to research centre visits and the acceptable 
recruitment rate show that the novel approach taken in this pilot trial is worthy of investigation 
in future randomized trials.  
It was difficult to recruit the required number of patients for this pilot trial. Although our 
recruitment rate was acceptable (62%), not all patients agreed to take part in the trial and few 
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(n=13) were referred to our centre. Patients had several reasons for refusing to participate in 
the study including lengthy travel distances to the research centre and insufficient time to 
commit to the study. The low recruitment rate in this trial may be due to the fact that patients 
with early stages of AC are usually seen by primary care centres who prescribe patient 
medications and refer them to physiotherapy facilities. The variable course of AC, the 
variations in referral patterns as many practitioners are involved in the care of AC, the delays 
from referral to specialist assessment, and the diagnostic uncertainty of AC limited us from 
recruiting enough patients to this trial. In the future, large trials on patients with AC may be 
best conducted at a primary care clinical setting.  
The research team leader (SA) was not part of the clinical team and this also may have affected 
recruitment of subjects for the study. In spite of the research leader regularly communicating 
with other clinical team members such as physiotherapists and administrative people, the 
recruitment was lower than expected. As this is a critical issue, improving communication 
between researchers and clinical team members may be important.  
In this trial, the rate of recruitment (62%) was acceptable and the rate of adherence (97%) was 
excellent, with only one patient lost to a final follow-up session. Patients were required to 
participate in many assessment sessions, an initial assessment session and in three more 
assessment sessions (at three weeks, six weeks, and 12 weeks), and to attend physiotherapy 
treatment sessions or perform the home exercise program. Both of these programs involved 
time and effort from patients. This suggests that with the current methodology, a future study 
is feasible and performing advanced statistical analysis with larger sample sizes seems 
achievable. However, it is important to take into account that AC is a disabling condition and 
patients are usually eager to try something to get their shoulder feeling better. If it was less 
disabling, the adherence to the program would likely be lower.  
Due to the random and concealed allocation of patients in this trial, selection bias was 
minimized. In addition, patients in this trial were blinded to treatment groups, PT vs. PT+, and 
were randomly referred to physiotherapy facilities that might minimized performance bias. 
However, since some patients were given a home exercise program by the research leader, 
there may be a source of performance bias. Further, the research leader performed all the 
assessments and was aware of group allocations which is considered a source of detection bias. 
The attrition rate was minimal during the baseline, three weeks, and six weeks assessment 
sessions, however, at 12-week assessment session, one patient was lost to follow-up with an 
attrition rate of 13%. Lastly, based on our initial registered protocol, all the mentioned primary 
and secondary outcomes were collected and reported in this trial which minimized reporting 
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bias. However, there was an intention to collect data at 24-week follow-up session, but because 
patients were unwilling to attend this session, no data was collected.    
The main aim of all AC physiotherapy programs is to relieve pain, improve function, increase 
shoulder ROM and to improve the patient's quality of life. In the current literature, there is no 
consensus on the most appropriate treatment for AC in patients with and without diabetes.[20,46] 
Several studies have shown that physiotherapy interventions (mainly exercises) reduce pain, 
restore shoulder function, and improve ROM in patients with and without diabetes who have 
AC [15–18,47–51], which concur with the results of the current trial. However, the recovery might 
be similar [52] or inferior [21] to patients without diabetes contradicting the results of this pilot 
trial. Because of the very low sample size of patients with diabetes in this pilot trial, comparing 
its results to other studies could be misleading.  
The improvements in shoulder pain, function and motion of the shoulder joint following 
physiotherapeutic interventions may be explained by the mechano-transduction mechanism by 
which cells convert external mechanical stimuli  or force (e.g. exercise and massage) into a set 
of biochemical reactions that elicit adaptive responses in the tissue. For example, controlled 
self-stretching exercises and vacuum massage are reported to be effective in promoting 
collagen remodeling and maturation by breaking down adhesions and inducing collagen 
realignment. These changes in turn reduce motion restriction, decrease pain and improve 
function [53,54].  
Fitbit Zip was reported as a valid activity tracker for recording step count and covered distance 
[38]. Our results in Table 3 showed some discrepancies between steps count and the actual 
covered distance. Therefore, we would question the accuracy of this type of activity trackers 
and recommend for the use of more accurate types of activity trackers in future trials.   
Lastly, no previous research has investigated the effect of incorporating specific shoulder 
exercises with aerobic training program to investigate shoulder recovery in patients with 
diabetes who have AC. Aerobic exercises that improve hyperglycemia and insulin sensitivity 
in skeletal musculature may have an impact on the pathophysiology of AC. Because none of 
our patients with diabetes were randomized to the group that include regular walking program, 
examining this effect was not possible. Future studies are required to examine the effect of 
adding walking program to the shoulder specific exercises for managing AC and to assess if 
walking is the ideal aerobic exercise for this population or other aerobic programs such as 
swimming or biking.  
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3.4.1 Strengths and limitations  
 
The strengths of this study are: (1) All assessment sessions were performed by the research 
leader which reduced assessment variations among patients; (2) This trial reduced selection 
bias by having a computerized randomization process; (3) In this trial, the surgeon and the 
research leader were trained and experienced in the field of shoulder rehabilitation which 
contributed to the successful conduct of this trial. However, there are some limitations to this 
pilot that need to be recognized: (1) Having a small sample size has reduced the power of this 
trial; (2) The inability to blind the outcome assessor has introduced detection bias to this study; 
(3) Since no patient with diabetes were randomized to the walking program, examining the 
effect of incorporating aerobic program to specific shoulder exercise for managing AC was not 
possible. However, future studies considering a walking program for patients with diabetes 
must consider the presence of diabetic foot as this may prevent the ability of patients to do 
walking due to the potential adverse effect of weightbearing exercises on foot health [44].   
 
3.4.2 Clinical impacts and future research directions  
 
- This study suggests that physiotherapeutic exercises might be effective in reducing pain 
and improving shoulder function in patient with and without diabetes who have AC.  
- Based on the findings of the current pilot trial, we have calculated the sample size for 
future randomized trials; for a trial to have 80% power ((α= 0.05, β=0.20), and to detect 
20% difference between-groups, it would require a minimum of 89 participants per 
group and 178 participants in-total. 
- Rigorous randomized controlled trials are needed to define the optimal combination of 
physiotherapy interventions for managing AC in patients with and without diabetes. 
- Future trials should be well-designed to minimize biases and should be reported using 
CONSORT criteria [55].  
- Better reporting of standardized outcomes is needed including reliable and responsive 
measures of physical activity level (RAPA) and FIT-HaNSA. Standardized 
measurement instruments would improve the quality of existing research and contribute 
to the ability to conduct meta-analysis in future.  
- The research team members have identified some barriers to patients’ recruitment. 
Future trials should be aware of the possible challenges of conducting a large-scale 
randomized trial.  
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3.5 Conclusion 
 
This randomized pilot trial established that conducting a large-scale study to assess the effect 
of physiotherapy program for managing AC is feasible. However, the effect of adding 
progressive walking program to PT  exercises was not tested for patients with diabetes due 
to the stratified randomization with this small sample; all patients with diabetes were 
randomized to the regular PT program group. The current findings suggest that physiotherapy 
exercises may be effective in reducing pain and improving shoulder function and ROM in 
patients with and without diabetes who have AC. Researchers should be aware of the 
recruitment challenges and should work on minimizing performance and detection bias by 
blinding study personnel and outcome assessors.  
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Figure 1: Flow diagram of the pilot study  
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Table 1: Clinical characteristics of patients (n = 8) 
 
 
Variable 
Group allocation 
 
 
All patients 
PT PT + 
 
Number of patients 6 2 8 
Age: mean ± SD (range) years 56±8 (43 - 65) 61±4 (59- 64) 57±8 (43- 65) 
Sex (M:F) 4:2 1:1 5:3 
Affected side (n) 
Right 
Left 
Both  
 
1 
5 
 
1 
 
1 
 
2 
5 
1 
Duration of AC (months) 17±27 (2 - 72) 6±1 (5- 7) 14±23 (2 -72) 
BMI  26±4 (18 - 30) 21±4 (18- 23) 24±5 (18 - 30) 
Diabetes (yes / no) 3:3 0:2 3:5 
Diabetes duration (years) 5±7 (6 - 17) -- -- 
Heart disease (n) 1 1 2 
Hypertension (n) 3 -- 3 
Stomach ulcers (n) 1 -- 1 
Kidney disease (n) 1 -- 1 
Depression (n) 1 -- 1 
Osteoarthritis (n) 3 -- 3 
Back pain (n) 3 1 4 
 PT: regular physiotherapy group, PT+: regular physiotherapy plus walking program, n: number, SD: standard 
deviation, M: male, F: female, AC: adhesive capsulitis, BMI: body mass index.  
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Table 2: Descriptive analysis of outcome measures for PT and PT+ groups  
 
 
Outcome 
Baseline 
(Mean ± SD) 
 
At three weeks 
(Mean ± SD) 
At six weeks 
(Mean ± SD) 
At 12 weeks 
(Mean ± SD) 
 
PT 
(n= 6) 
PT+ 
(n = 2) 
All 
patients 
PT 
(n = 2) 
PT+ 
(n = 2) 
All 
patients 
PT 
(n = 2) 
PT+ 
(n = 2) 
All 
patients 
PT 
(n = 6) 
PT+ 
(n = 1) 
All 
patients 
FIT-HaNSA (Seconds) 
Task 1 
Task 2 
Task 3 
Tasks average  
 
151±89 
88±56 
125±60 
121±68 
 
300±0 
237±89 
177±4 
238±47 
 
189±102 
124±90 
151±74 
155±89 
 
-- 
-- 
-- 
 
-- 
-- 
-- 
 
-- 
-- 
-- 
 
163±71 
124±97 
189±87 
159±85 
 
243±81 
212±125 
276±34 
244±80 
 
183±77 
146±103 
211±85 
180±88 
 
-- 
-- 
-- 
 
-- 
-- 
-- 
 
-- 
-- 
-- 
SPADI (Pain %) 69±16 61±4 67±14 60±26 64±6 61±22 54±25 45±10 52±22 38±30 64 42±29 
SPADI (Function %) 56±19 61±4 57±16 50±28 54±6 51±24 40±28 35±8 38±24 23±29 73 30±32 
SPADI (Total %) 61±16 62±4 61±13 54±27 58±6 55±23 45±26 39±1 44±22 30±28 69 35±29 
RAPA  6±2 5±2 8±1 6±2 6±1 6±2 6±2 7±1 6±2 6±2 8 6±2 
AROM (Flexion- degrees) 
 
102±31 125±14 107±29 104±19 130±14 111±21 107±13 128±11 112±15 116±14 100 114±14 
AROM (Abduction- degrees) 
 
68±10 95±7 75±15 78±8 87±25 81±12 82±19 99±1 86±18 95±24 70 91±24 
AROM (External rotation- 
degrees) 
24±6 39±13 28±10 33±14 47±9 37±14 35±8 47±2 38±9 45±11 20 41±14 
Muscle strength (Shoulder 
flexors- kg) 
10±4 11±3 10±4 10±5 12±5 11±5 11±5 11±3 11±4 13±5 8 12±5 
Muscle strength (Shoulder 
abductors- kg)  
8±4 12±1 9±4 9±6 11±3 10±5 11±4 11±1 10±4 12±5 5 11±5 
FIT-HaNSA: Functional Impairment Test - Hand and Neck/ Shoulder/Arm, PT: regular physiotherapy group, PT+: regular physiotherapy plus walking program, SD: 
standard deviation, SPADI: shoulder pain and disability index, RAPA: rapid assessment of physical activity questionnaire, AROM: active range of motion. 
 
  
 
 80 
Table 3: Description of groups physical activity level  
 
Week/ Variable  Fitbit (steps) (Mean ± SD) 
 
Fitbit (distance -km) (Mean ± SD) Walking program (n=2) 
Time (minutes)  
PT 
 
PT+ 
 
All PT PT+ All N1 N2 
Week 1 (PT: n = 6; 
PT+: n = 1) 
4861±2674 8199 4670±3168  3.6±2.2 5.6 3.5±2.5 40 55 
Week 2 (PT: n= 6; 
PT+: n = 2) 
5476±2247 4919±3773 5337±2389 4.3±1.7 5.5±0.1 4.6±1.5 40 45 
Week 3 (PT: n= 6; 
PT+: n = 2) 
4208±1963 7302±1514 4981±2266 3.5±2.3 5.2±1.1 3.9±2.1 40 29 
Week 4 (PT: n= 5; 
PT+: n = 2) 
5695±2057 7854±382 9850±10319 4.2±2.0 6.0±0.3 4.0±2.2 60 42 
Week 5 (PT: n= 5; 
PT+: n = 2) 
4501±1781 7224±249 5279±1972 3.5±1.4 5.1±0.2 3.9±1.4 0 30 
Week 6 (PT: n= 4; 
PT+: n = 2) 
4556±3342 7846±53 5652±3096 3.8±3.1 6.1±0.8 4.6±2.7 0 50  
Total  4883±2344 7224±1194 5962±3868 3.8±2.1 5.6±0.5 4.1±2.1 180 251 
PT: regular physiotherapy group, PT+: regular physiotherapy plus walking program, SD: standard deviation. 
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Table 4: A comparison of outcome measures between patients with and without diabetes  
 
 
Variable 
Baseline 
(Mean ± SD) 
 
At three weeks 
(Mean ± SD) 
 
At six weeks 
(Mean ± SD) 
 
At 12 weeks 
(Mean ± SD) 
 
Diabetes 
(n = 3) 
No diabetes 
(n = 5) 
Diabetes 
(n = 3) 
No diabetes 
(n = 5) 
Diabetes 
(n = 3) 
No diabetes 
(n = 5) 
Diabetes 
(n = 3) 
No diabetes 
(n = 4) 
Clinical characteristics: 
Age  
Sex (M:F) 
BMI 
AC duration   
 
53±11 
2:1 
24±6 
29±38 
 
61±4 
3:2 
25±4 
6±2 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
FIT-HaNSA (seconds) 
Task 1 
Task 2 
Task 3 
 
112±31 
79±47 
97±35 
 
234±103 
152±103 
183±74 
 
-- 
-- 
-- 
 
-- 
-- 
-- 
 
136 ±16 
92 ±58 
184 ±101 
 
211 ±87 
178 ±116 
226 ±81 
 
-- 
-- 
-- 
 
-- 
-- 
-- 
SPADI (Pain) 77±10 61±13 71±11 56±26 67±6 43±23 31±26 50 ±32 
SPADI (Function) 67±1 52±19 61±5 45±29 47±16 33±28 12 ±10 44 ±38 
SPADI (Total) 71±4 55±14 65±4 49±28 55±12 37±25 19 ±16 48 ±33 
RAPA  5±2 6±2 6±3 6±2 6±2 6±2 7 ±2 6 ±2 
AROM (Flexion) 83±38 122±8 92±20 122±11 97±3 121±11 118 ±16 110 ±14 
AROM (Abduction) 65±5 81±17 77±7 83±15 73±3 94±19 100 ±26 85 ±23 
AROM (External 
rotation) 
23±7 31±11 27±6 43±14 30±10 43±4 45 ±17 39 ±13 
Muscle strength 
(Shoulder flexors) 
10±1 10±5 10±4 11±5 11±5 11±4 14 ±4 11 ±6 
Muscle strength 
(Shoulder abductors)  
6±2 10±4 6±4 12±5 10±4 10±4 12 ±3 11 ±7 
M: male, F: female, AC: adhesive capsulitis, FIT-HaNSA: Functional Impairment Test - Hand and Neck/ Shoulder/Arm, SD: standard deviation, SPADI: shoulder pain and 
disability index, RAPA: rapid assessment of physical activity questionnaire, AROM: active range of motion 
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Table 5: A comparison of physical activity level of patients with and without diabetes 
 
 
Week/ Variable 
Fitbit (steps) (Mean ± SD) 
 
Fitbit (distance -km) (Mean ± 
SD) 
Diabetes No-diabetes Diabetes No-diabetes 
Week 1 (diabetes: n= 
3; no diabetes: n= 5) 
5320±3547 4280±3280 4.0±3.0 3.1±2.4 
Week 2 (diabetes: n= 
3; no diabetes: n= 5) 
5577±3191 5193±2198 4.0±2.4 5.0±0.8 
Week 3 (diabetes: n= 
3; no diabetes: n= 5) 
3645±2874 5783±1647 3.4±3.5 4.2±1.1 
Week 4 (diabetes: n= 
3; no diabetes: n= 4) 
4708±2267 6435±1825 3.2±2.6 4.9±1.4 
Week 5 (diabetes: n= 
3; no diabetes: n= 4) 
4830±2365 5616±1922 3.8±1.8 4.0±1.3 
Week 6 (diabetes: n= 
3; no diabetes: n= 3) 
4595±4092 6710±1967 3.9±3.8 5.2±1.6 
Total  4779±3056 5670±2140 3.7±2.9 4.4±1.4 
SD: standard deviation  
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Abstract 
 
Objectives: The purpose of this study was to assess whether diabetes affects functional and 
physical outcomes following shoulder arthroplasty. 
Methods: A cohort of 140 patients were tested preoperatively, at an early follow-up visit 
(between 3-6 months) and at late follow-up visit (between 1-3 years) following shoulder 
arthroplasty. The American Shoulder and Elbow Surgeons (ASES) Standardized Shoulder 
Assessment Form measured shoulder pain and function and the Short-Form-12 (SF-12) 
measured physical health status. Shoulder goniometry and dynamometry were used to assess 
motion and strength. Diabetic status was self-reported. 
Results: There were significant improvements in function and physical health status for both 
patients with diabetes and patients without diabetes at the late follow-up visit. For patients with 
diabetes, shoulder function (ASES: 0-30) improved from 5 (5) to 18 (6) scores (p < 0.001) and 
physical health status improved from 27 (6) to 38 (8) scores (p < 0.001). For patients without 
diabetes, shoulder function improved from 8 (5) to 19 (8) scores (p < 0.001) and physical health 
status improved from 31 (8) to 40 (12) scores (p < 0.001). No significant differences between 
patients with diabetes and patients without diabetes was detected at the late follow-up session.  
Conclusion: Patients with diabetes achieve large clinical benefits from shoulder arthroplasty 
that are similar to outcomes observed in patients without diabetes. Future prospective studies 
with a larger sample size of patients with diabetes are needed to confirm the results of this 
study.  
Level of evidence: III 
 
Keywords: Diabetes, Function, Muscle strength, Physical health status, Range of motion, 
Shoulder arthroplasty   
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4.1 Introduction  
 
Shoulder arthroplasty surgery replaces the damaged humeral head and glenoid with prosthetic 
implants. This surgical procedure has been shown to significantly reduce pain, restore joint 
function and improve shoulder range of motion (ROM) at 2 years and beyond in patients who 
underwent total shoulder arthroplasty (TSA) or hemiarthroplasty (HA) [1–4]. Osteoarthritis is 
the primary diagnosis for 77% of shoulder arthroplasty and often occurs in middle-aged or 
older adults. Hence, comorbid health problem can be prevalent; including  hypertension and 
diabetes  which have been reported in in 63% and 20%, respectively [5]. 
Diabetes has been shown to be an independent risk factor for increased non-home discharge 
and longer hospital stays following shoulder arthroplasty [6,7]. Further, diabetes, along with 
hypertension and obesity, are reported to predict increased postoperative complications such 
as humeral fracture and joint infection [8]. Previous research found weak associations between 
patient satisfaction,  physical impairment and patient-reported functional outcomes in patients 
who have undergone  arthroplasty [9]. This  may reflect the diversity in presentation, patient 
priorities and expectations. While it is known that diabetes is associated with poor outcomes 
in ROM and patient-reported function after total knee arthroplasty [10], it is unknown whether 
this is also true for shoulder arthroplasty. 
The prevalence of diabetes is increasing (from 11% in 2010 to 14% by 2030) [11] and the 
negative impact of hyperglycemia on body tissue [12] may have an adverse effect on 
postoperative complications and length of hospital stays [7,8]. There is a need to investigate 
whether diabetes affects functional outcomes and motion after shoulder arthroplasty. The 
purpose of this study was to investigate the impact of diabetes on pain, patient-reported 
function, physical health status, and impairments in shoulder ROM and muscle strength in 
patients who underwent shoulder arthroplasty.  
4.2 Materials and Methods 
 
4.2.1 Study design and patients  
 
A retrospective analysis of a prospective cohort of 140 patients undergoing shoulder 
arthroplasty at an upper extremity surgical unit was conducted. Patients' demographic 
characteristics were collected and recorded into a computerized database before the surgical 
intervention (Baseline), and at the time of early follow-up visit (3-6 months), and again at the 
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time of their late follow-up visit (1-3 years). Shoulder pain, function, ROM, muscle strength, 
and physical health status were examined across these three time-points. In this study, patients 
were classified into two groups: patients with diabetes and patients without diabetes based on 
self-report using the Self-Administered Comorbidity Questionnaire (SCQ) which is an efficient 
method to classify comorbidity that corresponds with medical record abstraction  [13]. This 
cohort included patients who were treated with a mix of surgical interventions such as TSA, 
HA, and reverse TSA (rTSA). The local Research Ethics Board (REB) approved the study and 
written consents were obtained from all patients before the study.   
 
4.2.2 Outcome measures 
 
4.2.2.1 Primary outcome 
The primary outcome measure of shoulder was pain and function assessed using the American 
Shoulder and Elbow Surgery (ASES) Standardized Shoulder Assessment Form [14]. The ASES 
has been shown to be a valid and responsive measure of shoulder pain and function after 
shoulder arthroplasty [15]. A full description of this form is published [14]. The minimal clinically 
important difference (MCID) value for shoulder pain on the Visual Analogue Scale (VAS: 0-
10) is a decrease of 1.6 points and for the 100-point ASES scale is an increase of 13.6 points.[16] 
In this study, information from patients' self-evaluation [pain severity (VAS: 0-10) and 
activities of daily living (0-30 scores per side)] was collected. ASES scores were compared to 
norms established in an age-matched controls [17]. 
 
4.2.2.2 Secondary outcomes 
The secondary outcomes included ROM, muscle strength and physical health status.  
Physical health status was assessed using the Physical Component Summary (PCS) of the Short 
Form-12 (SF-12) survey [18]. The SF-12 has been shown to be a valid and reliable assessment 
tool [18] and has been used to assess patients after shoulder arthroplasty [19]. The MCID is 4.5 
points for the PCS on the SF-12 survey [20].  
Shoulder ROM was assessed in flexion, abduction, and external and internal rotation using a 
standard goniometer. Shoulder ROM was measured using standardized procedures with known 
high reliability (Intraclass Correlation Coefficients (ICCs) > 0.97) [21–23]. The MCID values for 
shoulder active forward flexion is 12, active abduction is 7, and active external rotation is 3 
[16].  
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Isometric shoulder flexion, abduction, external rotation and internal rotation muscle strength 
was assessed with the JTech PowerTrack handheld dynamometer (JTech; JTech Medical, Salt 
Lake City, UT, USA) [concurrent validity [24] and reliability (ICCs 0.89-0.98)] [25]. Shoulder 
muscle strength and ROM scores were compared to norms established in an age-matched 
controls and with similar testing procedures [26,27]. 
 
4.2.3 Inclusion and exclusion criteria  
 
Patients were included if they completed the SCQ to identify the presence of diabetes; the 
ASES and/or the SF-12 questionnaires; and if their shoulder muscle strength and ROM were 
measured at baseline, at early follow-up and at late follow-up visits. Exclusion criteria 
included inability or refusal to complete tests/measures. 
 
4.2.4 Statistical analysis  
 
Statistical analyses were performed using SPSS, version 23 (SPSS Inc., Chicago, IL, USA). 
Descriptive statistics were performed to evaluate normality using a Kolmogorov-Smirnov (K-
S) test. Descriptive statistics were calculated for the patients' demographics, and for each 
outcome measure at each time point. Continuous measures were reported as means and 
standard deviations and categorical measures were reported as numbers and percentages. In 
bivariate analysis, patients with and without diabetes groups were compared using independent 
sample t-test for continuous data (age and all outcomes measures at baseline) and Chi-square 
test for categorical data. A General Linear Model (GLM) with repeated measures was used to 
assess significant differences in the primary and secondary measures over time, and between 
patients with and without diabetes at baseline, at early follow-up and at late follow-up visits 
while controlling for the type of surgery (total arthroplasty, reverse total arthroplasty, and 
hemiarthroplasty) and the indication for surgery. Mauchly’s test was used to assess the 
assumption of sphericity. When sphericity was violated, degrees of freedom (df) were corrected 
using Huynh-Feldt estimates of sphericity [28]. To assess the effectiveness of the surgical 
intervention, we calculated the between group effect sizes by reporting the Standardized 
Response Mean (SRM) = δᵪ / SDδᵪ. The δᵪ is the mean between-group differences, and the 
SDδᵪ is the pooled standard deviation reflecting the variability of change between the two 
groups. To allow and facilitate clinical decision making, benchmark values of trivial (< 0.20), 
small (≥ 0.20 to < 0.50), moderate (≥ 0.50 to < 0.80) or large (≥ 0.80), proposed by Cohen, 
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were utilized [29]. An alpha level () of 0.05 was used to indicate statistical significance. 
Significant interactions were followed by pairwise comparisons using a Bonferroni correction.  
 
4.3 Results  
 
4.3.1 Descriptive statistics 
 
Patients who underwent shoulder arthroplasty and met the inclusion criteria were included in 
the analysis of ASES (n=140), SF-12 (n=103), shoulder ROM (n=140), and shoulder muscle 
strength (n=127). The demographic characteristics of patients who completed one or both 
surveys are summarized in Table 1 and the demographic characteristics of patients whose 
shoulder ROM and muscle strength were measured are summarized in Table 2. No significant 
differences between patients with and without diabetes were observed for age, sex, affected 
side, reason for surgery, and the type of surgical intervention. Within this cohort, 55% of the 
patients were treated with total shoulder arthroplasty, 30% of the patients were treated with 
reverse total shoulder arthroplasty, and 15 % of the patients were treated with hemiarthroplasty. 
The main reason for surgery was joint arthritis (73%) while other reasons included shoulder 
fractures, dislocation and rotator cuff arthropathy (27%).  Patients were tested at baseline (pre-
operative), and at two time-point post-surgery: at the early follow-up visit (3-6 months), and 
again at the late follow-up visit (1-3 years). 
 
4.3.2 Effect of surgical interventions   
 
4.3.2.1 Primary outcome 
Table 3 presents the means and SD of the responses for the ASES pain and function scores at 
each point in time. There was significant improvement over time (from baseline to late follow-
up visit) on pain scores (VAS: 0-10) for patients with diabetes [7 (3.3) to 2 (2.4), p < 0.001], 
and for patients without diabetes [6 (3.0) to 2 (2.3), p < 0.001].  
Similarly, there were significant improvements over time on function scores (ASES: 0-30) of 
the affected shoulder for patients with diabetes [5 (4.6) to 18 (6.3), p < 0.001] and for patients 
without diabetes [7 (4.9) to 19 (7.3), p < 0.001]. Pairwise comparisons revealed a significant 
improvement between each time point (p < 0.001) for the function score of the affected 
shoulder, and between baseline and late follow-up visit for pain scores.  
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Despite the higher pain (non-significant) and poorer function (mean difference (MD)= 3 points, 
p = 0.032) of patients with diabetes at baseline, the differences between groups became 
nonsignificant at the late follow-up visit (Table 3).  
 When we controlled for the type of surgery and indication for surgery the improvement over 
time in ASES pain and function scores remained significant (p < 0.001) and the differences in 
pain and function between patients with and without diabetes remained nonsignificant. In 
addition, the interaction between time and type of surgery and between time and reason for 
surgery were nonsignificant, indicating that surgical subgroups experienced similar patterns of 
recovery.  
 
4.3.2.2 Secondary outcomes  
There was significant improvement over time, between baseline and early follow-up visit and 
between baseline and late follow-up visit on the physical health status for patients with diabetes 
[27 (5.7) to 38 (8.2), p < 0.001] and for patients without diabetes [31 (7.5) to 40 (11.5), p < 
0.001] (Table 3). Despite the significant poorer physical health status of patients with diabetes 
at baseline (MD= 4 points, p < 0.033), both groups recovered to a similar physical health status 
at the late follow-up visit (Table 3).  
As shown in Table 3, there was a significant improvement over time of the affected shoulder 
ROM for both groups (p < 0.001). The independent sample t-test revealed significant 
differences between groups at baseline in flexion (MD = 13 degrees, p < 0.02), and abduction 
(MD = 11 degrees, p < 0.044). However, these differences became nonsignificant at the late 
follow-up visit.  
Similar to shoulder ROM, muscle strength of the affected shoulder significantly improved over 
time for both groups (p < 0.001) as shown in Table 3. Despite the significantly weaker shoulder 
flexors (MD = 2 kg, p < 0.013), abductors (MD = 2 kg, p < 0.001), and external (MD = 1 kg, 
p < 0.009) and internal (MD = 1kg, p < 0.006) rotator muscle groups at baseline, patients with 
diabetes regain similar muscle strength as patients without diabetes at the late follow-up visit.  
The analysis of covariance, when the type of surgery and indication for surgery were controlled 
for, revealed that the improvements over time in physical health status, ROM and muscle 
strength remained significant (p < 0.001) and the differences between patients with diabetes 
and patients without diabetes remained nonsignificant for physical health status, ROM and for 
muscle strength. In addition, the interaction between time and type of surgery and between 
time and reason for surgery were non-significant for the secondary outcome measures.  
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4.4 Discussion  
 
This study demonstrated that patients with and without diabetes have equally positive 
improvements in shoulder function, ROM, strength and in physical health status following 
shoulder arthroplasty, despite the small but significantly poorer function and physical health 
status that patients with self-reported diabetes present with prior to surgery. In addition, the 
improvements in shoulder pain, function, and ROM of the current study all reached statistical 
and clinical significance with large effects size (Table 3), confirming prior studies that indicate 
a large benefit to patients treated with shoulder arthroplasty. The overall improvements in 
shoulder pain, function, ROM, and strength as well as physical health status were comparable 
to previous studies despite the differences in sample size, outcome assessment tools, the follow 
up periods, and the inclusion criteria [1–4,19]. However, none of these studies have examined a 
subset of patients with diabetes for comparison. 
Similar to previous research [3,4], different types  of surgery (TSA, HA, rTSA) were not 
significantly different in terms of functional improvements following surgery. This may be 
because the indications for different surgeries successfully allocates them to the type of surgery 
providing the optimal outcome for that clinical presentation. However,  our results differ from 
one study that reported a greater shoulder ROM and less pain following TSA as compared to 
hemiarthroplasty [1]. 
Despite the reported improvements in shoulder ROM and strength, patients with and without 
diabetes had below-normal scores when compared to age-matched people with unaffected 
shoulder [26,27]. The lower scores can be attributed to several factors including the quality of the 
surrounding musculotendinous structures, the type of implant and fixation used, the general 
health status of patients, and the presence of comorbidities [2,4,8,30]. Patients should be made 
aware that improvement, not normality, is the expected outcome of surgery. 
The clinical improvements in outcomes between patients with and without diabetes was 
previously investigated following total knee arthroplasty (TKA) [10]. The TKA study included 
20 patients with diabetes with a mean age of 72 years. Similar to our study, there were small 
(non-significant) differences in knee ROM, muscle strength and Knee Society Score 
questionnaire scores between groups at baseline. However, at one year follow-up, TKR patients 
with and without diabetes had similar outcomes except for knee flexion which was significantly 
less (10) in patients with diabetes [10]. According to the authors, the difference in the 
rehabilitation program intensity explained the poorer knee flexion in patients with diabetes [10]. 
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Overall, our findings concur with results found in TKA, that patients with diabetes achieve 
similar clinical benefits, as compared to their patients without diabetes counterparts. 
 
4.4.1 Strength and limitations 
 
This study provides new information on the impact of diabetes on shoulder pain, function, 
ROM, strength and physical health status after shoulder arthroplasty. The data of this study 
were prospectively collected using valid and reliable outcome measures; and the ASES scale 
and SF-12 survey have been used to assess functional outcomes and physical health status after 
shoulder arthroplasty. We evaluated a relatively large cohort of patients and used an 
independent assessor to evaluate outcomes. However, several limitations of the current cohort 
should be recognized. First, diabetes status was based on self-report which is subject to 
reporting errors. However, the Katz self-administered comorbidity scale (SCQ) has been 
validated to assess comorbid conditions in health services research and is equivalent to 
extracting this information from medical records [13]. Diabetes is a condition that is likely 
accurately self-reported because of the associated treatment requirements. Second, and 
potentially more limiting was the fact that we did not have data about the type, the duration, 
the treatments of diabetes, and the level of glycemic control. It is possible that negative of 
effects of diabetes would be selectively present in with longer duration or poorer control. 
Therefore, we cannot preclude that negative effects occur in this subgroup. Lastly, although 
we controlled for the type of surgery and the indication for surgery and found no effect, 
recovery could be affected by other uncontrolled factors such as the quality and type of implant 
and the post-operative complications [1,2].  
 
4.5 Conclusion  
 
Patients with and without diabetes are expected to gain similar large clinical improvements in 
shoulder function, motion, strength and physical health status following shoulder arthroplasty. 
However, these improvements are not expected to reach normal values. Future large cohort 
studies with larger numbers of patients with diabetes and more rigorous evaluation of diabetes 
duration, type, and the level of glycemic control over a longer period of time could more 
accurately estimate the prognosis of different subgroups of patients with diabetes; and whether 
a dose-response relationship between glycemic control and outcomes is present.  
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Table 1: Demographic characteristics of patients who underwent shoulder arthroplasty and 
completed one or both of the self-reported surveys 
 
Variable  ASES SF-12 
Diabetes Diabetes 
Yes No Yes No 
Total number (n) 28 (20%) 112 (80%) 20 (19%) 83 (81%) 
Age (years) 
 
75 (9) 70 (11) 73 (9) 73 (8) 
Sex: Male 
        Female 
10 (7%) 
18 (13%) 
47 (34%) 
65 (46%) 
9 (9%) 
11 (11%) 
36 (35%) 
47 (46%) 
Dominant side: Right  
                           Left  
24 (17%) 
4 (3%) 
104 (74%) 
8 (6%) 
18 (18%)* 
2 (2%)* 
75 (74%) 
7 (7%) 
Affected side:  Right  
                         Left   
21 (15%) 
7 (5%) 
66 (47%) 
46 (33%) 
17 (17%) 
3 (3%) 
47 (46%) 
36 (35%) 
Medical problems: 
Heart disease    
Hypertension 
Lung disease  
Primary osteoarthritis  
Rheumatoid arthritis  
Others (cancer, depression, kidney 
and blood disease) 
 
7 (5%) 
18 (13%)* 
6 (4%)* 
24 (17%) 
2 (1%) 
34 (24%) 
 
22 (16%) 
36 (26%) 
5 (4%) 
83 (59%) 
22 (16%) 
116 (83%) 
 
7 (7%)* 
14 (14%)* 
3 (3%) 
17 (17%) 
2 (2%) 
26 (26%) 
 
11 (11%) 
25 (24%) 
4 (4%) 
55 (53%) 
11 (11%) 
81 (79%) 
Reason for surgery:  
Arthritis 
Rotator cuff tear 
Others (fracture, dislocation, revised 
surgery) 
 
16 (13%) 
3 (2%) 
9 (6%) 
 
60 (47%) 
4 (3%) 
48 (33%) 
 
11 (11%) 
1 (1%) 
8 (8%) 
 
51 (50%) 
3 (3%) 
29 (28%) 
Type of surgery: 
Total arthroplasty 
Reverse total arthroplasty  
Hemiarthroplasty   
n = 26 
16 (12%) 
8 (6%) 
2 (2%) 
n = 110 
63 (47%) 
36 (26%) 
11 (9%) 
 
11 (11%) 
6 (6%) 
3 (3%) 
 
50 (49%) 
23 (23%) 
9 (9%) 
Independent sample t-test was used to detect difference in age (mean (SD)) between groups. Chi-square test was 
used to detect differences between groups in all categorical data (reported as number and percentage). 
*Significant difference between groups, p < 0.05. ASES: American Shoulder and Elbow Surgeons, SF-12: Short 
Form-12 survey. 
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Table 2: Demographic characteristics of patients who underwent shoulder arthroplasty and 
whose shoulder motion and/or muscle strength were measured  
 
Variable  ROM  Muscle strength 
Diabetes Diabetes 
Yes No Yes No 
Total number (n) 27 (19%) 113 (81%) 23 (18%) 104 (82%) 
Age (years) 
 
73 (8) 71 (9) 74 (9) 70 (9) 
Sex: Male 
        Female 
12 (9%) 
15 (11%) 
54 (39%) 
59 (42%) 
11 (9%) 
12 (9%) 
51 (40%) 
53 (42%) 
Dominant side: Right  
                           Left  
24 (17%) 
3 (2%) 
104 (74%) 
9 (6%) 
21 (17%) 
2 (2%) 
97 (76%) 
7 (6%) 
Affected side:  Right  
                         Left   
23 (16%)* 
4 (3%)* 
70 (50%) 
43 (31%) 
20 (16%)* 
3 (2%)* 
66 (52%) 
38 (30%) 
Medical problems: 
Heart disease    
Hypertension 
Lung disease  
Primary osteoarthritis  
Rheumatoid arthritis  
Others (cancer, depression, 
kidney and blood disease)  
 
8 (6%)* 
17 (12%)* 
5 (4%)* 
23 (16%)* 
3 (2%) 
32 (23%) 
 
14 (10%) 
34 (24%) 
3 (2%) 
62 (44%) 
12 (9%) 
90 (64%) 
 
5 (4%) 
16 (13%)* 
4 (3%) 
20 (16%)* 
2 (2%) 
27 (22%) 
 
14 (11%) 
35 (28%) 
7 (6%) 
68 (54%) 
12 (9%) 
89 (69%) 
Reason for surgery:  
Arthritis  
Rotator cuff tear 
Others (fracture, dislocation, 
revised surgery) 
 
16 (13%) 
2 (2%) 
10 (8%) 
 
60 (46%) 
1 (1%) 
46 (35%) 
 
14 (14%) 
1 (1%) 
7 (6%) 
 
63 (54%) 
1 (1%) 
40 (33%) 
Type of surgery: 
Total arthroplasty 
Reverse total arthroplasty  
Hemiarthroplasty  
 
19 (14%) 
6 (5%) 
2 (1%) 
 
65 (48%) 
36 (26%) 
11 (8%) 
 
15 (12%) 
6 (5%) 
2 (2%) 
 
62 (50%) 
31 (25%) 
9 (7%) 
Independent sample t-test was used to detect difference in age (mean (SD)) between groups. Chi-square test was 
used to detect differences between groups in all categorical data (reported as number and percentage). 
*Significant difference between groups, p < 0.05. ROM: range of motion.  
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Table 3: A comparison of changes in pain, function, ROM, and muscle strength between patients with 
and without diabetes who underwent shoulder arthroplasty  
General linear modules-repeated measures were used to detect changes over time and between groups. Values are reported 
as mean (SD). *significant effect of time (p < 0.05) between baseline and early follow-up visit and between baseline and 
late follow-up visit. †significant mean difference between groups as detected by independent sample t-test.  
ROM: Range of Motion, ASES: American Shoulder and Elbow Surgeons, SF-12: Short From-12 survey.  
 
  
Variable  Baseline Early follow-up visit 
(3-6 months) 
Late follow-up visit 
(1-3 years) 
Effect size 
Diabetes Diabetes Diabetes 
Yes No Yes No Yes No 
ASES  
Pain (0-10) 
Function: Affected side (0-30) 
              Un-affected side (0-30) 
 
7 (3) 
5 (5)† 
21 (8) 
 
6 (3) 
8 (5) 
22 (8) 
 
2 (1)* 
13 (5)* 
24 (5)* 
 
2 (2)* 
15 (7)* 
24 (6)* 
 
2 (2)* 
18 (6)* 
25 (4)* 
 
2 (2)* 
19 (8)* 
25 (6)* 
 
1.0 
0.9 
SF-12 
Physical health status (0-100) 
Mental health status (0-100) 
 
27 (6)† 
48 (13) 
 
31 (8) 
53 (11) 
 
35 (8)* 
48 (12) 
 
39 (9)* 
55 (9) 
 
38 (8)* 
53 (6) 
 
40 (12)* 
53 (10) 
 
0.6 
Shoulder ROM (degrees): 
Flexion: Affected  
             Unaffected   
 
Abduction: Affected  
                  Unaffected   
 
External rotation: Affected 
                           Unaffected 
   
Internal rotation: Affected 
                           Unaffected   
 
85 (31)† 
146 (33) 
 
65 (23)† 
137 (39) 
 
20 (12) 
57 (21) 
 
3 (3)† 
53 (19) 
 
98 (24) 
153 (22) 
 
76 (25) 
150 (26) 
 
24 (12) 
61 (21) 
 
6 (10) 
51 (16) 
 
108 (18)* 
156 (19)* 
 
90 (21)* 
150 (25)* 
 
36 (18)* 
64 (21) 
 
24 (11)* 
55 (16) 
 
112 (26)* 
158 (21)* 
 
96 (28)* 
152 (27) 
 
36 (18)* 
62 (22) 
 
27 (15)* 
52 (15) 
 
132 (28)* 
156 (21) 
 
115 (33)* 
150 (32) 
 
47 (16)* 
70 (15)* 
 
37 (14)* 
60 (13) 
 
132 (32)* 
155 (22) 
 
119 (36)* 
152 (26) 
 
47 (23)* 
68 (19)* 
 
38 (19)* 
55 (19) 
 
2.2 
 
 
0.7 
 
 
0.5 
 
 
0.2 
 
Shoulder muscle strength (kg): 
Flexors: Affected  
             Unaffected 
 
Abductors: Affected 
                 Unaffected  
 
External rotators: Affected  
                           Unaffected 
   
Internal rotators: Affected  
                           Unaffected   
 
2 (1)† 
5 (2)† 
 
2 (1)† 
5 (2)† 
 
2 (1)† 
4 (2)† 
 
3 (2)† 
6 (2) 
 
4 (3) 
7 (5) 
 
4 (3) 
8 (5) 
 
3 (1) 
6 (3) 
 
4 (2) 
8 (7) 
 
4 (2)* 
5 (2) 
 
4 (2)* 
6 (2) 
 
3 (2)* 
5 (2) 
 
4 (2) 
6 (2) 
 
5 (4)* 
7 (4) 
 
5 (3)* 
8 (4) 
 
3 (2)* 
6 (2) 
 
5 (2) 
8 (4) 
 
4 (2)* 
5 (2) 
 
4 (1)* 
5 (2) 
 
4 (2)* 
5 (1) 
 
4 (2)* 
6 (2) 
 
5 (3)* 
6 (3) 
 
5 (3)* 
7 (3) 
 
4 (2)* 
6 (2) 
 
6 (3)* 
7 (3) 
 
1.4 
 
 
1.0 
 
 
1.0 
 
 
1.4 
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Abstract 
 
Background: Shoulder arthroplasty has been shown to improve function in patients with 
advanced shoulder disease. However, the response to surgery and final outcomes are not easily 
predictable. This study assessed the effect of residual pain, age, sex, diabetes, hypertension, 
and depression on changes and status at one-year following arthroplasty with respect to 
shoulder function and overall physical and mental health status.  
Methods: A retrospective analysis of a prospective cohort of 140 patients tested preoperatively 
and one-year following shoulder arthroplasty was conducted at our tertiary hospital. Pearson's 
correlations and multiple regression analyses were performed to test the impact of predictors 
on shoulder pain and function assessed using the American Shoulder and Elbow Surgery 
(ASES) questionnaire, and on physical and mental health assessed using the Short Form-12.  
Results: Pain and female sex were significant predictors of poorer function at one-year (R = 
0.56, p = 0.001); and with other predictors, they explained 32% of the variability in function. 
The explained variability of changes in function scores was 15% with pain being the only 
significant predictor. Physical health was lower in older patients (r = -0.31, p < 0.05) and was 
less predictable for physical health change scores (12%) and the physical status at one-year 
(14%).  
Conclusions: Residual pain is associated with poorer function status and less clinical benefit. 
Female sex is not associated with less change in function which suggest that men and women 
get equal benefit from the surgery. Advanced age relates to poorer physical health and to a 
lesser extent physical change over the year.     
Level of evidence: III 
Keywords: Function, Physical health status, Shoulder arthroplasty  
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5.1 Introduction  
 
Shoulder arthroplasty is widely used to treat patients with severe arthritic changes in the joint 
[1]. This surgical procedure has been shown to be effective in reducing pain, improving shoulder 
function and increasing range of motion (ROM) [2,3]. However, the overall improvement in 
shoulder functional outcomes is not always predictable and can be influenced by several factors 
[4]. These factors were examined by several studies [2,4,5];  however, the results of these studies 
have conflicted with one another. Young age was associated with better shoulder function on 
constant score at one-year follow-up after hemiarthroplasty performed for patients with 
proximal humeral fracture [6]. Further, the improvement of shoulder clinical scores over time 
was associated with young age at the time of shoulder arthroplasty surgery but not with the 
later follow-up years in patients with rheumatoid arthritis [5]. In contrary, advanced age was 
associated with greater improvement (change) in shoulder function as demonstrated on the 
Simple Shoulder Test (SST) following total shoulder arthroplasty (TSA) [2]. However, other 
studies found no correlations between age and the improvement in shoulder function [4,7]. 
Lastly, studies that assessed the effect of gender on the improvement in shoulder function found 
that men had better post-operative function assessed using SST [4,7].  
Physical health is expected to decline with age [4] and be adversely affected by comorbidities 
[8]. However, factors that influence physical health following shoulder arthroplasty have rarely 
been examined. Advanced age is negatively associated with physical function (r = -.23) and 
the better pre-operative physical health is associated with better post-operative physical 
function (r = .4) as demonstrated on the Short Form-36 (SF-36) survey following  TSA [4].    
The presence of comorbidities, including diabetes and hypertension, have been shown to have 
no effect on post-operative shoulder function [7,9], except for internal rotation ROM (R = -.2) 
which was decreased with diabetes [9]. However, depression has been associated with lower 
shoulder function assessed using the American Shoulder and Elbow Surgery (ASES) in 176 
patients 2-year following TSA [10].  
There are few studies which addressed the factors that influence postoperative functional 
outcomes following shoulder arthroplasty. In addition, a number of these studies do not report 
regression coefficients or explain the effect size attributable to these predictors. This makes it 
difficult to determine how much these should influence decision-making. Finally, 
comorbidities such as diabetes, hypertension and depression are rarely examined although they 
are present in 20-60 % of patients undergoing shoulder arthroplasty [1].  
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Identifying preoperative factors that are predictive of one-year outcomes could assist surgeons 
and health care providers in providing patients more realistic expectations on outcomes and 
may help plan postoperative pain management and rehabilitation. Therefore, the current study 
was designed to address the following questions: 1) Do age, sex, diabetes, hypertension, and 
depression predict patient-reported outcomes including shoulder pain and function, and 
physical and mental health status one-year following shoulder arthroplasty? 2) Do these factors 
predict the clinical benefits following surgery as reflected in the change of outcome scores? Is 
residual pain (pain at one-year) associated with poorer functional outcomes?  
 
5.2 Materials and methods 
 
5.2.1 Study design and patients  
 
A retrospective query of prospective collected data of patients who underwent shoulder 
arthroplasty was conducted at a tertiary care referral hospital. Demographic data were collected 
and recorded into a computerized database for 477 patients with shoulder arthroplasty. All 
patients who completed the ASES (n = 140) and the SF-12 (n = 103) questionnaires at baseline 
and at one-year follow-up visits and who completed a self-reported comorbidity survey (n = 
140) were included in this analysis. This cohort included all patients treated with shoulder 
arthroplasty regardless of the type of surgery based on a previous study[11] that showed non-
significant differences in ASES and SF-12 scores between patients with different surgical 
intervention (TSA, reverse TSA, hemiarthroplasty). Exclusion criteria included an inability or 
refusal to complete tests/measures. The University Ethics board approved the protocol and 
written consents was obtained from all patients.  
 
5.2.2 Outcome measures 
 
The dependent variables included the ASES [12], which assessed shoulder pain and function, 
and the SF-12 which assessed physical and mental health status [13]. Both questionnaires have 
been shown to be valid and reliable self-reported assessment tools [13,14] and have been 
previously used to assess patients after shoulder arthroplasty [10]. In this study, self-reported 
pain severity (VAS: 0-10) and activities of daily living (maximum 30 scores) information were 
obtained from the ASES. The Physical Component Summary Score (PCS) and the Mental 
Component Summary Score (MCS) scores were obtained from the SF-12. A full description 
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of ASES and SF-12 questionnaires has previously been published [12,13]. Both questionnaires 
were administered preoperatively and at one-year follow-up visit. Next, scores from both 
questionnaires were averaged and were compared among patients based on their age, sex, and 
the presence of diabetes, hypertension, and depression (Table 1). To estimate the clinical 
benefits of shoulder arthroplasty, we calculated the change in scores from baseline 
(preoperative) to the one-year follow-up visit for the ASES function and SF-12 PCS.   
 
5.2.3 Predictors (independent variables)  
 
The predictive variables of interest included patient demographics: age and sex, and 
comorbidities: diabetes, hypertension and depression. Patients with a preoperative self-report 
of diabetes, hypertension, and depression were identified and were designated to the study 
cohort. The prediction effect of these factors has been examined twice; first on the final scores 
at one-year for ASES pain and function and for SF-12 PCS and MCS, and second on the change 
of scores from baseline to one-year follow-up visit for ASES function and SF-12 PCS. 
 
5.2.4 Statistical analysis  
 
Statistical analyses were performed using SPSS software, version 23 (SPSS Inc., Chicago, IL, 
USA). A P value of <.05 was considered statistically significant.  Independent sample t-test 
was used to detect differences in the ASES and the SF-12 scores between patients based on the 
predictive variables: patients demographics (age and sex) and the presence of comorbidities 
(diabetes, hypertension, depression). All values are reported as mean and standard deviation 
(SD). Pearson's correlation coefficients (r) were calculated between the dependent and 
predictive variables and between the predictive variables. The effect size of Pearson's 
correlations were classified as follow: r = +/- 0.1= small effect, r = +/- 0.3 = medium effect, r 
= +/- 0.5 = large effect [15]. Next, a multivariable enter regression analysis was performed to 
examine the effect of the predictive variables on the improvement in ASES and SF-12 one-
year following shoulder arthroplasty. For ASES, pain at one-year was added to a second 
multivariable enter regression model as a predictive variable to examine its effect on function. 
To predict the clinical benefits of shoulder arthroplasty, we calculated the change in ASES 
function and SF-12 PCS scores by subtracting scores at one-year follow-up visit from baseline 
scores. Then, a multivariable enter regression analysis was performed on the change scores of 
ASES function and SF-12 PCS. All the assumptions of multiple regression including the test 
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of normality, heteroscedasticity, multicollinearity and linearity were examined prior to the 
regression analysis.   
5.3 Results  
 
5.3.1 Descriptive statistics  
 
Within this cohort, 140 patients completed the ASES and 103 patients completed the SF-12 
survey. The average age of patients was 71 years (range, 47-89 years). 57% of patients 
underwent TSA, 33% underwent reverse TSA and 10% underwent hemiarthroplasty.  
Table 1 represents the influence of the patients' demographics on ASES and SF-12 scores one-
year following shoulder arthroplasty. For ASES, age was significantly different between 
patients in all subgroups (p <0.05). Males and patients with depression were younger than 
females and patients without depression while patients with diabetes and hypertension were 
older than patients without these two conditions. Males had significantly better function 
compared to females (r = -0.27, p = 0.001) (Table 2). For the SF-12, patients with depression 
were younger and had worse mental health status compared to patients without depression 
(Table 1).   
 
5.3.2 Pearson's correlations 
 
Pearson's correlation between dependent variables and predictors are summarized in Table 2. 
The coefficients ranged from -0.31 to 0.20. There were significant correlations (p <0.05) with 
a small effect size between ASES pain and depression, ASES function and sex, MCS and sex, 
MCS and depression, and a medium effect size between PCS and age. Patients with depression 
reported higher pain and worse mental health status, male patients had better shoulder function 
and mental health status, and younger patients had better physical health status (Table 2). 
When pain at one-year was added as a predictor to examine its effect on function, results 
revealed a moderate relationship between residual pain and function (r = -0.51, p <0.001) 
indicating that patients with higher pain had poorer shoulder function. In addition, there was a 
negative association between the change in function scores and residual pain (r = -0.36, p 
<0.001) indicating that patients who reported pain at one-year follow-up visit had less 
improvement in shoulder function.  
Pearson's correlations were performed to examine collinearity between predictors. For ASES 
pain and function, results revealed significant correlations between diabetes and hypertension 
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(r = -0.25, p < 0.002) and between age and depression (r = 0.26, p < 0.001).  For SF-12 PCS 
and MSC, results revealed significant correlations between diabetes and hypertension (r = -
0.33, p < 0.001) and between age and depression (r = -0.34, p < 0.001). However, these 
correlations are weak [15]. We concluded that there is no collinearity within our data.  
 
5.3.3 Multivariable regression analysis 
 
The regression model is summarized in Table 3. In predicting pain, depression was the only 
significant predictor of pain (b = 1.5, SE = 0.63, t (140) = 2.4, p = 0.02) indicating that the 
presence of depression increases pain by 1.5 units. Together, all predictors explained 6% of the 
variability in pain.  
For shoulder function, sex was a significant predictor of function (b = -4.2, SE = 1.3, t (140) = -
3.2, p = 0.002) indicating that being a male improves shoulder function by 4.2 scores on ASES 
index. All predictors explained 8% of the variability in function. When pain at one-year was 
added as a predictor in the final model, results revealed that both sex and pain (b = -1.6, SE = 
0.24, t (140) = -6.7, p < 0.001) were significant predictors of function. This indicated that as pain 
increases by one unit, shoulder function decreases by 1.6 scores. The explained variability in 
function increased to 32% with a greater contribution of pain.  
In predicting the clinical benefits of shoulder arthroplasty, only residual pain was a significant 
predictor of the change in function scores (b = -1.1, SE = 0.26, t (140) = -4.4, p < 0.001). This 
indicated that with 1 unit increase in residual pain, the improvement of shoulder function 
decreases by 1.1 scores. Together, all predictors explained 15% of the variability in the 
improvement in function.  
In predicting SF-12 physical and mental health status, age was a significant predictor of 
physical health status (b = -0.48, SE = 0.15, t (103) = -3.3, p = 0.001). With one-year increase in 
age, physical health status decreases by 0.5 scores. Depression had a trend to predict mental 
health status (b = -6.1, SE = 3.2, t (103) = -1.9, p = 0.058). Together, all predictors explained 
14% of the variance in physical health status and 10% of the variance in mental health status.   
In predicting the change in PCS, none of the predictors were significant. However, there was 
a trend for both age and hypertension to predict the change in PCS (p = 0.055). The explained 
variability in PCS change scores was 12%.   
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5.4 Discussion  
 
This study found that residual pain at one-year after shoulder arthroplasty is associated with 
poorer shoulder function. In addition, residual pain is the most significant predictor of function, 
and with other predictors, it explains 32% of the variability in shoulder function one-year after 
shoulder arthroplasty. Furthermore, residual pain is found to be the only predictor of 
improvement in shoulder function and clinical benefits following shoulder arthroplasty.  
It is well established that shoulder pain can significantly affect function and the ability to 
perform activities of daily living [16] and pain relief is the primary goal of patients who undergo 
shoulder arthroplasty [17]. However, for some patients, post-surgical pain persists 1-2 years 
after shoulder arthroplasty, being most problematic for patients with fractures or osteoarthritis 
[18]. Our study found that residual pain at one-year is reported by 61% of patients who 
underwent shoulder arthroplasty but is highly variable in intensity (range: 0.2 - 10, VAS scale).  
In addition, higher pain is associated with worse shoulder function. Higher pain may be related 
to arthritis in the contralateral shoulder or in other parts of the arm since often outcome 
measures do not differentiate the location of the pain. However, it is also possible that closer 
attention to pain peri-operatively and during rehabilitation could improve these outcomes.  
In our study, statistically significant poorer shoulder function is associated with female sex. In 
addition, although female sex is associated with lower functional scores, it is not associated 
with less change in function which suggest that men and women get equal benefit from the 
shoulder arthroplasty. Furthermore, women are more likely to have a negative change in mental 
health following surgery in comparison to men (Table 2). We showed that pain is highly related 
to poor shoulder function and, although not significant, women tend to report higher pain 
(Table 1). This may explain the poorer shoulder function for women. These findings are 
consistent with previous studies in which male patients had better improvement in function at 
a longer follow-up periods ranged from 2 to 6 years following TSA [2,7].  
In the present study, age is not a significant factor in predicting the change in shoulder scores 
nor the one-year shoulder function. However, age relates significantly to physical health status, 
in which younger patients had better physical health status, and to a lesser extent physical 
change over the year but not to mental health.  
These findings are consistent with the study of Donigan et al. (n = 106) who reported a non-
significant correlations between age and improvement in shoulder function [7]. However, 
advanced age was associated with significant better change in shoulder function in one study 
2-year after TSA (n = 102) [2] and with less improvement in shoulder function at the time of 
 
 107 
surgery [5] and at one-year follow-up [6] after shoulder arthroplasty. Advanced age was also 
associated with lower physical health status in the study of Matsen et al. [4].  In addition, Matsen 
et al. [4] reported that the overall well-being of patients before TSA is strongly correlated with 
the quality of the outcomes [4].  
These conflicting findings might be related to the conflicting mechanisms by which age can 
mediate outcomes. Advanced age is associated with lower occupational and life demands for 
most people. Further, shoulder disorders and pathologies are common in older adults and are 
associated with general decline in physical health and quality of life [8,19]. However, in our 
regression analysis, we showed that age is not a significant predictor of the change in physical 
health status. This may indicate that physical health status is expected to improve following 
shoulder arthroplasty regardless to age. Other reasons for the conflicting conclusions among 
studies may include the use of different patient-reported assessment tools, the differences in 
the inclusion criteria, and the various sample sizes.  
In general, comorbidities including diabetes, hypertension, and depression did not affect the 
final outcome status nor the amount of improvement gained with surgery for shoulder function, 
and physical and mental health status of this cohort' patients following shoulder arthroplasty. 
However, depression is associated with higher levels of pain and there is a trend toward worse 
mental health status (p = 0.058). Our inability to show significant correlations between function 
and comorbidities is consistent with previous research [7,9]. These results are also consistent 
with our previous research [11] in which we showed that patients with and without diabetes 
recovered to the same functional level at one-year following shoulder arthroplasty despite 
significantly worse pre-operative function in patients with diabetes. We concluded that patients 
with diabetes achieve large clinical benefits from shoulder arthroplasty, with follow-up 
outcomes equally positive to those without diabetes[11]. However, the non-significant 
association between depression and shoulder function may be due to our low sample size of 
patients with depression (n = 17). This lack of association differs with the study of Werner et 
al. [10] who reported significant effect of depression on ASES scores and shoulder function in 
88 patients with depression [10]. Our regression model showed a significant effect of depression 
on ASES pain in which depression, with other predictors, explained 6% of the variability of 
pain. However, the low percentage of the explained variability in pain might not have a clinical 
importance. Werner et al. [10] did not include a subscale of ASES pain for comparison.  
 
5.4.1 Strength and limitations 
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This study provides new information about the impact of age, sex, diabetes, hypertension and 
depression on shoulder pain and function, and physical and mental health status one-year 
following shoulder arthroplasty. The data of this study were collected prospectively from a 
large cohort of patients who underwent shoulder arthroplasty. Shoulder pain and function, and 
physical and mental health status were evaluated using valid and reliable outcomes measures 
which have been used previously by several studies [4,10]. However, this study has several 
limitations. As with all regression models, a significant statistical relationship does not imply 
causation. Further, in some of our models, the explained variation was small and thus the 
clinical importance of statistically significant correlations must be questioned. Our data was 
derived from a single specialty upper extremity program and may not be generalizable to other 
clinical practices. We cannot distinguish the location of pain and thus residual pain is not 
necessarily related to the operated shoulder. However, none of these limitations diminish the 
value of this study which presented important information in a way that allow clinicians to 
incorporate its findings into their decision-making when planning for this surgical procedure.  
 
5.5 Conclusion  
 
This study found that residual pain is associated with poorer shoulder function at one-year and 
less clinical benefits over time. Female sex is associated with worse shoulder function at one-
year but not with less change in function over time which suggests that men and women get 
equal benefit from the surgery. Comorbidities do not affect the final outcomes status and the 
amount of improvement gained with surgery. Advanced age relates to poorer physical health 
status and to a lesser extent physical change over the year. Lastly, patients with depression had 
higher pain than patients without this condition. Identifying risk factors for poor functional 
outcomes following shoulder arthroplasty can assist clinicians in counselling patients on the 
expected outcome following shoulder arthroplasty. 
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Table 1: Patient demographics and its influence on ASES and SF-12 one-year following shoulder arthroplasty  
 
Patient's 
demographics   
ASES (n = 140) SF-12 (n = 103) 
 
Number of 
patients (%) 
Age 
Mean (SD) 
Pain: 
(VAS:0-10) 
Mean (SD) 
Function: 
(scores: 0-30) 
Mean (SD) 
Number of 
patients (%) 
Age (years) 
Mean (SD) 
PCS 
(scores: 0-100) 
Mean (SD) 
MCS 
(scores: 0-100) 
Mean (SD) 
Sex: Male 
        Female  
57 (41) 
83 (59) 
68 (12)* 
73 (9) 
1.5 (2) 
2 (2) 
20 (8)* 
17 (7) 
45 (44) 
58 (56) 
72 (7) 
73 (8) 
42 (11) 
38 (11) 
55 (8) 
52 (10) 
Diabetes: Yes 
                 No 
28 (20) 
112 (80) 
75 (9)* 
70 (11) 
2 (2) 
2 (2) 
18 (6) 
18 (8) 
20 (19) 
83 (81) 
73 (9) 
73 (8) 
38 (8) 
40 (12) 
53 (6) 
53 (10) 
Hypertension: Yes 
                         No 
54 (39) 
86 (61) 
74 (8)* 
69 (12) 
2 (2) 
2 (2) 
18 (7) 
19 (7) 
39 (38) 
64 (62) 
74 (7) 
72 (8) 
38 (11) 
41 (11) 
51 (10) 
54 (9) 
Depression: Yes 
                     No 
17 (12) 
123 (88) 
64 (8)* 
72 (11) 
3 (3) 
2 (2) 
18 (6) 
18 (8) 
11 (11) 
92 (89) 
65 (9)* 
74 (7) 
39 (8) 
40 (11) 
48 (12)* 
54 (9) 
Independent sample t-test was used to detect differences between groups for each predictor (mean (SD)). *Significant difference between groups at P < 0.05. ASES: 
American Shoulder and Elbow Surgeons, SF-12: Short Form-12 survey, PCS: physical component summary, MCS: mental component summary.  
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Table 2: Pearson's correlations between predictors and dependent variables one year 
following shoulder arthroplasty 
 
Dependent variables  Predictors 
 
Age Sex Diabetes Hypertension Depression 
 
ASES:  
Pain at 1-year 
Function: Model 1 
Demographics+ comorbidities 
Function: Model 2 
Demographics+ comorbidities 
+ residual pain  
Change in function scores 
 
 
0.1 
 
-0.02 
 
 
-0.02 
0.03 
 
0.11 
 
-0.27* 
 
 
-0.27* 
-0.09 
 
0.01 
 
-0.07 
 
 
0.01 
0.11 
 
0.06 
 
0.01 
 
 
-0.07 
-0.01 
 
 0.2* 
 
-0.03 
 
 
-0.03 
-0.02 
SF-12:  
PCS at 1-year 
Change in PCS scores 
MCS at 1-year 
 
-0.31* 
-0.17* 
0.08 
 
-0.14 
-0.17 
-0.18* 
 
-0.08 
0.07 
0.01 
 
-0.14 
-0.12* 
-0.15 
 
-0.03 
-0.07 
 -0.21* 
Change in scores was calculated by subtracting scores at one-year follow-up visit from baseline scores 
Function Model 1 predictors: age, sex, diabetes, hypertension, and depression.  
Function Model 2 predictors: pain at one-year, age, sex, diabetes, hypertension, and depression 
* Significant at P <0 .05. ASES: American Shoulder and Elbow Surgeons, SF-12: Short Form-12 survey, PCS: physical 
component summary, MCS: mental component summary.  
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Table 3: Regression model summary for dependent variables one year following shoulder 
arthroplasty 
 
Dependent variables  R R2 Adj. R2 SE F-statistics Sig 
 
ASES:  
Pain 
Function: Model 1 
Demographics+ comorbidities 
Function: Model 2 
Demographics+ comorbidities 
+ pain at one-year 
Change in function  
 
 
0.25a 
 
0.28 a 
 
 
0.56b 
0.38 b 
 
0.06 
 
0.08 
 
 
0.32 
0.15 
 
0.03 
 
0.05 
 
 
0.28 
0.11 
 
2.3 
 
7.3 
 
 
6.3 
6.8 
 
1.7 
 
2.3 
 
 
10 
3.9 
 
NS 
 
0.05 
 
 
0.001 
0.001 
SF-12: 
PCS  
Change in PCS 
MCS  
 
 0.37 a 
0.34 a 
0.31 a 
 
0.14 
0.12 
0.10 
 
0.09 
0.07 
0.05 
 
10.5 
10 
9.0 
 
3.0 
2.5 
2.0 
 
0.01 
0.033 
NS 
Dependent variables at one-year  
a Predictors: (constant), age, sex, hypertension, diabetes, depression  
b Predictors: (constant), pain at one-year, age, sex, hypertension, diabetes, depression 
Change in scores was calculated by subtracting scores at one-year follow-up visit from baseline scores 
 Function Model 1 predictors: age, sex, diabetes, hypertension, and depression.  
 Function Model 2 predictors: pain at one-year, age, sex, diabetes, hypertension, and depression 
 ASES: American Shoulder and Elbow Surgeons, SF-12: Short Form-12 survey, PCS: physical component 
summary, MCS: mental component summary, NS: nonsignificant.  
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CHAPTER 6: 
 
GENERAL DISCUSSION AND IMPLICATIONS 
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6.1 Overview of thesis findings  
 
This thesis focuses on understanding the impact of diabetes on shoulder conditions leading to 
a pilot study on a physiotherapy (PT) intervention that considers diabetes in management. This 
work addresses a gap in the literature since remarkably few studies have focused on managing 
adhesive capsulitis (AC) and shoulder recovery after arthroplasty in patients with diabetes. 
This work is completed as a manuscript thesis where following chapter one which reviews the 
relevant literature, a series of inter-related manuscripts are presented in individual chapters. 
In chapter two, a systematic review synthesizes the quality and content of clinical research 
addressing the effectiveness of non-surgical interventions for managing AC in patients with 
diabetes. The systematic review showed that low-quality evidence suggests large effects of 
joint mobilization plus exercises on AC in people with diabetes and weaker support was 
available for corticosteroid and manipulation under anesthesia (MUA). This systematic review 
has been published in the Archives of Physical Medicine and Rehabilitation journal.   
Chapter three included a pilot study that compared the effect of a regular PT program to a 
regular PT combined with a progressive walking program (PT+) in patients with and without 
diabetes who have AC. This pilot trial established that conducting a large-scale study to assess 
the effect of physiotherapy program for managing AC is feasible.  The current findings suggest 
that physiotherapy exercises may be effective in reducing pain and improving shoulder 
function and range of motion (ROM) in patients with and without diabetes who have AC. The 
sample size for future studies was also determined.  
Chapter four is a cohort study that evaluated the impact of diabetes on shoulder pain, function, 
ROM, and muscle strength outcomes as well as on physical health status following shoulder 
arthroplasty. This study has been published in the Journal of Clinical Orthopedics and Trauma. 
There was a significant improvement in all outcome measures for both patients with diabetes 
and patients without diabetes with no significant differences between groups at 1-3 years after 
surgery. We concluded that patients with diabetes achieve substantial clinical benefits from 
shoulder arthroplasty, with follow-up outcomes equally positive to those without diabetes.  
Chapter five is a cohort study that examined factors predicting shoulder function and clinical 
benefits one-year following shoulder arthroplasty. This study has been published in the Iowa 
Orthopedic Journal. We showed that residual pain (pain at one-year) and female sex were 
significant predictors of poorer function at one-year and residual pain was the only significant 
predictor of the explained variability of change in function scores. We concluded that residual 
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pain is associated with poorer function status and fewer clinical benefits. Female sex is not 
associated with less change in function which suggests that men and women get equal benefits 
from surgery. Advanced age relates to poorer physical health at one-year following surgery. 
Lastly, diabetes, hypertension, and depression neither affected shoulder function, nor physical 
and mental health status at one-year following shoulder arthroplasty.  
 
6.2 Key messages  
 
6.2.1 What is already known on this subject  
 
It has been consistently reported that people with diabetes are more frequently affected by AC 
with long-lasting symptoms and poor prognosis. Further, although some of the therapeutic 
interventions are effective in managing primary AC, several studies have reported higher 
shoulder pain, reduced mobility, poor functional outcomes, reduced quality of life, and a 
diminished response to treatment in patients with diabetes than patients without diabetes [1–3]. 
None of the previous systematic reviews focused on patients with diabetes or formally tested 
diabetes as a source of clinical heterogeneity in response to treatment. Given the potential 
differences in underlying mechanisms for patients with diabetes, it is unclear whether the 
recommendations for treatment of AC can be equally applied to the subset of patients with 
diabetes. 
Adhesive capsulitis occurs five times more often in people with diabetes [4]. Exercises are 
usually recommended to manage AC. However, the recovery is slow and often incomplete, 
especially for patients with diabetes. Aerobic exercises improve hyperglycemia and insulin 
sensitivity. Currently, no research has formally assessed the benefits of incorporating an 
aerobic training program into the treatment plan of AC in patients with diabetes. 
Shoulder arthroplasty has been shown to significantly reduce pain, restore joint function and 
improve shoulder ROM at two years and beyond [5]. While it is known that diabetes is 
associated with poor outcomes in ROM and patient-reported function after total knee 
arthroplasty [6], it is unknown whether this is also true for shoulder arthroplasty. Further, the 
response to shoulder arthroplasty surgery and the outcomes are not easily predictable. Factors 
such as age, gender, and the presence of comorbidities have been reported by a few studies to 
influence functional outcomes following shoulder arthroplasty [5].  
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6.2.2 What this thesis adds to the knowledge base 
 
Low-quality evidence suggests large effects of joint mobilization plus exercises on adhesive 
capsulitis in people with diabetes, although confidence in this conclusion is limited due to the 
high risk of bias. Even weaker support was available for corticosteroid and MUA. 
The pilot trial established that conducting a large-scale study to assess the effect of 
physiotherapy program for managing AC is feasible.  The current findings suggest that 
physiotherapy exercises may be effective in reducing pain and improving shoulder function 
and ROM in patients with and without diabetes who have AC. Future studies, with 80% power 
(α= 0.05, β= 0.20) to detect a 20% between-group difference, would require a sample size of 
89 participants per group. This will require a large hospital or several hospitals to manage. 
Patients with diabetes achieve large clinical benefits from shoulder arthroplasty, with follow-
up outcomes equally positive to those without diabetes. Future prospective studies with a larger 
sample size of patients with diabetes are needed to confirm the results of this study. 
Residual pain is associated with poorer function status and fewer clinical benefits. Female sex 
is not associated with less change in function which suggests that men and women get equal 
benefits from the surgery. Advanced age relates to poorer physical health. Diabetes, 
hypertension, and depression neither affected shoulder function, nor physical and mental health 
status at one-year following shoulder arthroplasty. 
 
6.3 Limitations  
 
Despite providing excellent insights into clinical approaches for diabetic shoulder, this thesis, 
on the whole, had one inherent limitation besides specific limitations of the individual studies 
included in it. We had time constraints that prevented us from recruiting enough subjects for 
the pilot study to examine the impact of incorporating an aerobic exercise program into the 
specific shoulder exercises for managing AC in patients with diabetes. However, we 
established a groundwork for future trials to assess this effect based on the experience that we 
gained from the pilot study.  
 
6.4 Implication of thesis findings  
 
The prevalence of diabetes among Canadian adults aged 20-79 years is expected to increase by 
14% in 2030 [7]. Patients with diabetes are more frequently affected by AC with long-lasting 
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symptoms and poor prognosis. A combination of exercises, joint mobilization techniques and 
steroid injection can be effective in reducing pain, improving shoulder function, and motion in 
patients with diabetes. 
In recent years, interest in the area of postoperative outcomes for patients following shoulder 
arthroplasty has increased rapidly, due to the increased volume of shoulder arthroplasty surgery 
and the improvement in prosthesis quality. Clinicians may expect the following: 
* Patients with and without diabetes gain similar large improvements in shoulder function, 
motion, and strength as well as physical health status after surgery;  
* The presence of pain at one-year following shoulder arthroplasty may cause limitations in 
shoulder function;   
* The presence of comorbidities such as diabetes, hypertension, and depression may not affect 
postoperative shoulder function and physical health status after the surgery.  
 
6.5 Future research directions and recommendations  
 
Rigorous RCTs that are designed to minimize bias and reported using the Consolidated 
Standards of Reporting Trials (CONSORT ) criteria [8] are needed to determine the best non-
surgical intervention, assess the effect of surgical interventions, and examine the effect of 
incorporating aerobic exercise program to the traditional physiotherapy program for managing 
AC in patients with diabetes.  
Future studies are encouraged to report the reliability and responsive measure of shoulder 
functional performance. The use of standardized measurements, protocols, and timing would 
improve the quality of existing trials and contribute to conducting meta-analysis in the future.  
Considering 38% of patients refused to participate in this pilot trial, future clinical trials should 
keep this ratio in mind before deciding on their sample size. A larger multicenter randomized 
clinical trial or a single-centre trial with a long period can help to recruit the required number 
of participants which in-turn can increase the power of any study.  
 
6.6 Overall summary  
 
Through this thesis, we have provided evidence-based information on the effect of different 
non-surgical interventions and determined the feasibility of a full-scale randomized clinical 
trial on managing AC in patients with diabetes. We examined the impact of diabetes on 
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shoulder recovery, and factors predicting shoulder function at one-year following shoulder 
arthroplasty.  
This final chapter provided a general discussion and formulated conclusions based on the 
previous research, including the most significant findings. We have also provided future 
research directions and recommendations.  
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